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ABSTRACT 
This study was carried out to assess and evaluate the effect of 
Morel’s disease vaccine for sheep. One hundred and seventy pus samples 
were obtained from sheep abscesses lymph node at meat inspection in 
three different abattoirs and subjected to bacteriological examination. 
Staphylococcus spp. were isolated from 68.8% of the pus samples, while 
Corynebacterium spp. were isolated from 26.5%. Mixtures of both 
organisms were isolated from the rest (4.7%) pus samples.  
Isolated staphylococci were subjected to further identification by 
biochemical tests and were found to be: 63.2% S. aureus subsp. 
anaerobius, 21.3% S. caseolyticus, 11.9% S. aureus, and 0.9% of each of 
S. simians, S. lugdunensis, S. warneri and S. epidermidis. 
In outbreak of the abscess disease of sheep in Alsamra village, 
Khartoum State, morbidity rate was 30%. Of the affected animals, 93.3% 
had Morel’s disease, as pus cultures of which yielded S. aureus subsp. 
anaerobius and the rest 6.7% had caseous lymphadentitis, as pus cultures 
of which yielded Corynebacterium spp. 
Comparison between the different isolates of S. aureus subsp. 
anaerobius using PCR based techniques (RAPD and polymorphism of 
coa and spa genes) showed that all Sudanese isolates were genetically 
identical. Complete sequence of the catalase gene of one outbreak isolate 
in addition to partial sequence of other two outbreak isolates, six from 
two different abattoirs and one reference strain was performed. Sequence 
results showed that all Sudanese isolates harbour a catalase gene which is 
distinct from the catalase gene of known reference strains suggesting that 
all Sudanese isolates originated from one clone. The deduce catalase-like 
protein encoded by the catalase gene of local Sudanese strains was found 
to be only 345 amino acids in length instead of 505 a.a. in S. aureus 
viii 
 
subsp. aureus (NCTC 8325 and Newman strains) and 445 a.a in S. aureus 
subsp. anaerobius strain MVF213. 
Ability of isolated staphylococci to induce abscess formation was 
tested. Except S. aureus and S. aureus subsp. anaerobius, none of the 
isolates was able to cause the clinical subcutaneous abscess of Morel’s 
disease and only S. caseolyticus formed caseated lymph abscess detected 
on post-mortem. 
Morel’s disease vaccine, made according to the method of Rodwan 
(1996), was injected into sheep at different doses. The animals were 
challenged with S. aureus subsp. anaerobius using three times the 
minimal abscess causing dose. The minimum protective dose of the 
vaccine was found to be 0.5 ml boostered by 0.25 ml after two weeks. 
This protocol minimized the known protective dose to the half.  
The protective ability of Morel’s disease vaccine against abscesses 
due to other two staphylococci was also tested. Lambs vaccinated with 
Morel’s disease vaccine were able withstand challenge by S. aureus or S. 
caseolyticus (no abscess formation in the sub cutis or in superficial lymph 
nodes). 
Assessment of the immunity of the sheep vaccinated with Morel’s 
disease vaccine was carried out using the Plaque Forming Cell Assay and 
by Opsonphagocytosis methods. Number of plaque antibody forming 
cells from vaccinated sheep was significantly higher (P<0.05) than from 
non vaccinated sheep. Bacteria opsonized for 2 hours by serum of 
vaccinated animals caused smaller subcutaneous abscesses in 
experimentally infected sheep when compared with that caused by non-
opsonized bacteria. Also, a sharp decrease in the number of opsonized 
bacteria was observed indicating that the serum antibodies in response to 
vaccination with Morel’s disease vaccine had greatly increased.  
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INTRODUCTION 
Morel’s disease is a non-fatal contagious disease of sheep. It is 
caused by Staphylococcus aureus subspecies anaerobius (shortly referred 
to as S. aureus anaerobius) and is encountered in lambs between 4-10 
months of age (Morel, 1911). The disease is endemic in nature with high 
morbidity rate and frequent relapses, but no mortality has been directly 
attributed to it (Bajmocy et. al., 1984). 
In the Sudan, Morel’s disease causes economical losses, especially 
among fattened sheep. Many shipments of exported sheep were sent back 
to Sudan due to this disease. 
Of 936,415 sheep returned from Saudi Arabia between 1990 and 
1998, 77% were rejected on the grounds of sheep abscess or Morel’s 
disease. This has initiated a discussion about producing vaccine for 
Morel’s disease in Sudan. At times, the Saudis may reject the whole 
shipment because of 1 or 2 abscess cases (Aklilu, 2002).  
Twenty-eight ships containing 113,415 heads of sheep prepared for 
exportation to the Gulf area were rejected in March 1992. However, the 
rejected number of sheep increased dramatically in April 1992, (373973 
heads) with a total loss of LS 7,564,600,000. The total loss of 8 years 
amounted to 15,142,800,000 Sudanese Dinars (Hassan, 2001). 
Morel’s disease was wrongly diagnosed in Saudi Arabia as 
“caseous lymphadenitis” or "pseudotuberculosis", which is caused by 
Corynebacterium ovis. Accordingly, a wrong vaccine was issued without 
any success (S. M. El Sanousi, personal communication). Hamad (1989) 
was the first to describe the disease in sheep in the Sudan. Rodwan (1996) 
produced a specific vaccine for Morel’s disease using a local Sudanese 
strain of S. aureus anaerobius. El haj (2002) produced this vaccine using 
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the IBT bioreactor technology. In this study, we tried to evaluate the 
efficacy of the vaccine by using some immunological methods. Molecular 
biology methods were used to see possible genetic differences between 
local Sudanese isolates for the purpose of choosing a vaccine strain. 
Staphylococcus species other than S. aureus anaerobius were isolated by 
Noura Karamalla (1997) and Sara Bihary (2002) from some abscesses of 
sheep. Verifying such isolates as additional causes of Morel’s disease was 
also aimed. 
Objectives of the study 
1- To survey for Morel’s disease among infected animals in search of 
different aetiological agents for sheep abscesses. 
2- To study the synergistic action of combined aetiology agents in 
causing the disease. 
3- To investigate possible genetic differences among the local strains 
of S. aureus anaerobius. 
4- To determine and evaluate the effective dose of the vaccine. 
5- To improve the potency and efficacy of Morel’s disease vaccine 
and to assess the immunity in vaccinated sheep. 
6- To evaluate immunity conferred by Morel’s vaccine in sheep by 
the use of immunological tests. 
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CHAPTER ONE 
LITERATURE REVIEW 
1.1 Abscess disease in sheep (Morel’s disease) 
Abscess disease is a disease of young sheep characterized by 
spontaneous abscess formation in subcutaneous and occasionally 
intermuscular tissue (Morel, 1911; Aynaud, 1927; Aynaud, 1928; Shirlaw 
and Ashford, 1962 and Bajmocy et al., 1984). According to Morel (1911) 
and Bajmocy et al. (1984), the disease is usually encountered in 8–10 
months old lambs and it occurs in almost all lambs that are born in 
infected flocks. De La Fuente and Suarez (1985) considered it as a 
disease of young sheep of up to 4 months that rarely affected adults. 
Rodwan (1996) reported that 8 months to 3 years old sheep were 
generally affected, but animals around 1–5 years old were commonly 
affected. 
The disease was also known as Morel’s disease as it was firstly 
reported by Morel in 1911 in France (Shirlaw and Ashford, 1962 and 
Bajmocy et al., 1984). The disease was reported thereafter by other 
French scientists (Aynaud, 1922, 1927, 1928; Carré, 1923a, 1927; Benito 
and Borrel, 1957). In Hungary the disease was reported in 1983 in a flock 
of sheep imported from France (Bajmocy et al., 1984). In Spain, Blanco- 
Loizelier (1985) was the first to report the disease. De la Fuente and 
Suarez (1985) also described an outbreak of the disease in Spain. Afnan 
and Hedjazi (1978) reported the disease in Iran for the first time. The 
disease was diagnosed in Kenya in a flock of sheep, which was built over 
seven years from endogenous ewes crossed with pedigree Corridale rams 
(Shirlaw and Ashford, 1962). In Denmark outbreak of the disease was 
reported for the first time by Møler et al. (2000) in 4–5 months old sheep 
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imported from France. Hamad (1989) was the first to describe the disease 
in sheep in the Sudan.  
Goats are considered as naturally resistant to the disease. However, 
Valenti and Bieler (1984) reported spontaneously developing abscess 
disease in goats. The disease was also reported in goats in the Sudan by 
El Sanousi et al. (1989) and in Saudi Arabia by Alhendi et al. (1993).  
Møler et al. (2000) reported a gradual increase in the number of 
affected animals that reached 40% of the flock after five months of the 
outbreak. The disease was mainly diagnosed in animals of good health 
kept for fattening (Aynaud, 1923). Also Hassan (1996) reported the 
relationship between the onset of Morel’s disease and the fattening 
process as high as 62.5%. 
1.2 Pathology of abscess disease 
The main pathological character and the only sign of the disease is 
the abscess formation close to or within the superficial lymph nodes, and 
so, the disease is known as abscess disease (Aynaud, 1927). Aynaud 
(1922) and Shirlaw and Ashfford (1962) reported that the abscess 
developed close to - but not within - the lymph nodes, while Bajmocy et 
al. (1984) and  De La Feunete and Suarez (1985) found abscesses inside 
the superficial lymph nodes but not around them. Occasionally, abscesses 
were found in the lungs (Aynaud 1922; Bajmocy et al., 1984 and Hamad, 
1989). Møler et al. (2000) found that the abscesses were closely 
associated with lymph nodes and the abscess wall was often fused with 
the lymph node capsule by a connective tissue formation that was several 
millimetres thick.  
The most commonly affected lymph nodes are the prescapular, 
popliteal, inguinal and parotid lymph nodes (Morel, 1911). Aynaud 
(1927) and Joubert (1958) considered the angle of the jaw, the shoulder 
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point and the scrotum to be the predilection sites for abscesses. Shirlaw 
and Ashford (1962) mentioned that abscesses occurred in the following 
order of frequency: close to the prescapular, popliteal, parotid and 
anterior cervical lymph nodes. Bajmocy et al. (1984) noticed that 
suppuration occurred most frequently in the mandibular, prescapular and 
subiliac lymph nodes. De La Fuente and Suarez (1985) observed that 
abscesses most frequently located in the lymph nodes of the mandibular 
region (mandibular, parotid and lateral retropharyngeal) followed by 
superficial cervical, subiliac, popliteal, supramammary and scrotal lymph 
nodes, respectively. Hamad et al. (1992) mentioned that the distribution 
of suppurative lesions among naturally infected sheep involved the 
parotid, mandibular, prescapular, popliteal and other lymph nodes 
respectively. Møler et al. (2000) reported that the lesions predominantly 
occurred in prescapular region or in head: 54% of the abscesses were 
located in association with the superficial cervical lymph nodes followed 
by the parotid lymph nodes (27%) and the popliteal lymph nodes (11%). 
Naturally occuring abscess is variable in size. It could be as small 
as a pigeon’s egg or as large as an orange (Morel, 1911; Shirlaw and 
Ashford, 1962), two-hand fists (Aynaud, 1923), hen egg or a man’s fist 
(Bajmocy et al., 1984), or in size of a football (Alhendi, 1993) or 15 cm 
in diameter (Møler et al., 2000). Experimentally reproduced abscess 
could reach up to 6.5x6.0 cm in diameter (Hassan, 1996) or 9.9x9.4 cm 
according to Sara Bihary (2002).  
Lesions usually start small and then gradually increase in size; 
when ripened, the abscess ruptures expelling thin greenish yellow pus, 
while healing takes place after a long time (Morel, 1911; Aynaud, 1922; 
Bajmocy et al., 1984; De la Fuente and Suarez, 1985). However, Møler et 
al. (2000) reported that the abscesses were rounded and gradually 
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increased in size up to 10 cm in diameter and they fistulated 
spontaneously expelling a viscous white- yellow odourless mass and were 
enclosed by a 0.2-0.5 cm thick connective tissue capsule. Aynaud (1922) 
mentioned that ruptured abscesses might proliferate in other points 
adjacent to the first site. More than two abscesses might occur 
simultaneously on the same animal. However, Shirlaw and Ashford 
(1962), and Bajmocy et al., (1984) noticed that adjacent lymph nodes 
were usually involved a few weeks after those abscesses developing first 
had ruptured and healed. 
1.3 Abscess formation 
The sebaceous glands in the skin secrete factors that are 
bactericidal to Gram-positive bacteria. These factors include long- chain 
fatty acids and monoglycerides (Christensen, 1993; Kanai et al., 1978; 
Shryock et al., 1992 and Engler et al., 1992). Fatty acids metabolizing 
enzyme (FAME) has the ability to inactivate some of these fatty acids by 
esterification to cholesterol. This may help to lower fatty acid 
concentrations and possibly protect the organisms from killing 
themselves in search for other sources of nutrients (Chamberlain, 1999). 
FAME appears not only to function within abscesses, but also to assist in 
the organism's survival in host tissues (Mortensen et al., 1992 and Karbal 
et al., 1992). Lipase enzyme produced by the organism can break down 
the triglycerides from sebaceous gland secretions to glycerol and fatty 
acids. The fatty acids obtained from breakdown of triglycerides could be 
utilized by the bacteria.  If the fatty acid concentration gets too high, it 
can kill the staphylococci. The lipase enzyme is less active against the 
long-chain triglycerides produced in abscesses than it's against 
triglycerides with shorter side chains in the molecule (Muraoka et al., 
1982). 
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1.4 The causative agent of abscess disease in sheep 
Joubert (1958) isolated Gram-positive micrococci from lambs 
affected with abscesses similar to those formerly described by Morel 
(1911) and Aynaud (1922, 1923). Several workers (Carré, 1927; Shirlaw 
and Ashford, 1962; Bajmocy et al., 1984; and De la Fuente et al., 1985) 
confirmed the relation of these micrococci to abscess disease. Benito and 
Borrel (1957) and Joubert (1958) proposed the name Micrococcus 
pyogenes ovis and Micrococcus abscedens ovis for the organism. Blanco- 
Loizelier (1985) and De la Fuente et al. (1985) demonstrated that the 
aetiological agent of abscess disease was catalase and benzedine negative 
Staphylococcus; they considered it to be a respiratory deficient S. aureus. 
De la Fuente et al (1985) reported that this respiratory deficient S. aureus 
exhibits a cell wall composition typical of S. aureus ATCC12600.
 
DNA-
DNA hyperdization indicated that the organism was very closely related 
to S. aureus at the species level, and because of biochemical 
distinctiveness (catalase and benzedine negative, negative or weak growth 
under aerobic conditions). De la Fuente et al. (1985) classified it as S. 
aureus subsp. anaerobius, and thereafter was included in the nineth 
edition of Bergey’s Manual of Determinative Bacteriology (Sneath et al. 
1986). Morel (1911), Aynaud (1922) and Carré (1923a, b) mentioned that 
the organism did not grow on simple media or when incubated 
aerobically. Shirlaw and Ashford, 1962; Bajmocy et al., 1984 and De la 
Fuente et al., 1985 mentioned that a good growth of the organism occured 
when cultures were incubated anaerobically under CO2 tension, while 
Aynaud (1923) reported that the organism could grow aerobically when it 
was cultivated in Egg Yolk Agar. Shirlaw and Ashford (1962) showed 
that the organism did not grow aerobically even after five days of 
incubation, while Bajmocy (1984) noticed a pin point colonies on the 
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fifth day or later of incubation aerobically. Hamad (1989) and De la 
Fuente and Suarez (1985) noticed that after few subcultures on sheep 
blood agar under microaerophilic or anaerobic incubation, the organism 
can be adopt aerobic growth on. Møler et al. (2000) isolated S. aureus 
subsp. anaerobius in pure cultures, which were microaerophilic and 
appeared under aerobic condition as pin point colonies after 4–5 days. 
Under 10% CO2 tension or anaerobically, 0.5–1 mm beta-haemolytic 
white colonies developed after 48 hours of incubation on blood agar 
plates. 
1.5 Staphylococci isolated from sheep abscesses in the Sudan 
Many authors described the organisms that cause abscesses in the 
Sudan. They all agreed that the organism is Gram- positive cocci, 
arranged in pairs, tetrads and clusters and do not grow in simple media 
when incubated aerobically but they disagreed in the results of 
biochemical reactions, especially in the haemolysin production, 
coagulase, pigment production and colony size. 
 Noura Karamalla (1997) isolated twelve different Staphylococcus 
spp. from suppurating lymph node abscesses of 85 sheep at meat 
inspection in Alkadaro abattoir and from subcutaneous abscesses of 15 
fattened animals, viz; S. aureus subsp. anaerobius (26%), S. hyicus 
(22%), S. caseolyticus (20%), S. aureus (5%), S. hominis (4%), S. 
dolphini (5%), S. sciuri (4%), S. cohnii (3%) and S. xylosus (2%), while 
Sara Bihary (2002) isolated other different Staphylococcus spp., from 
lymph node abscesses of sheep at meat inspection in Omdurman abattoir, 
viz; S. aureus subsp. anaerobius (24%), S. sacchrolyticus (19%), S. 
aureus (10%), S. caseolyticus (10%), S. hyicus (10%), S. simulans (5%), 
S. carnosus (5%), S. caprae (5%), S. auricularis (5%), S. pulvereri (5%), 
S. lugdunensis (5%) and S. simians (5%). 
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S. aureus: mainly associated with gangrenous mastitis, dermatitis and 
pyaemia
 
(Timoney et al., 1988). Ewes are very sensitive to experimental
 
infection with S. aureus by the intramammary route; fewer than
 
100 
bacteria are sufficient to produce clinical mastitis. In man, S. aureus 
causes a variety of suppurative (pus-forming) infections and toxaemia 
(Watson,
 
1988). It causes superficial skin lesions such as boils, styes and 
furunculosis; more serious infections such as pneumonia, mastitis, 
phlebitis, meningitis, and urinary tract infections; and deep-seated 
infections, such as osteomyelitis and endocarditis. S. aureus is a major 
cause of hospital acquired (nosocomial) infections of surgical wounds 
and infections associated with indwelling medical devices (Zierdt et al., 
1982; Kenneth Todar University, 2008). Also it causes food poisoning by 
releasing enterotoxins into food, and toxic shock syndrome by release of 
superantigens into the blood stream.  
Staphylococcus aureus expresses many potential virulence factors 
such as surface proteins that promote colonization of host tissues; 
invasins that promote bacterial spread in tissues (leukocidin, kinases, 
hyaluronidase); surface factors that inhibit phagocytic engulfment 
(capsule, protein A); biochemical properties that enhance their survival in 
phagocytes (carotenoids, catalase production); immunological disguises 
(protein A, coagulase, clotting factor); and membrane-damaging toxins 
that lyse eukaryotic cell membranes (haemolysins, leukotoxin, 
leukocidin); exotoxins that damage host tissues or otherwise provoke 
symptoms of disease (SEA-G, TSST, ET); inherent and acquired 
resistance to antimicrobial agents. S. aureus can express proteases, lipase, 
deoxyribonuclease (DNase) and fatty acid modifying enzyme (FAME). 
The first three probably provide nutrients for the bacteria, and it is 
unlikely that they have anything but a minor role in pathogenesis. 
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However, the FAME enzyme may be important in abscesses, where it 
could modify anti-bacterial lipids and prolong bacterial survival (Kenneth 
Todar University, 2008).  
 
Fig. 1: Virulence determinants of Staphylococcus aureus (from Kenneth 
Todar University, 2008). 
 
- Staphylococcus hyicus: Originally described by Sompolinsky (1950). It 
is a causative agent of exudative epidermitis in pigs, an infectious skin 
disease characterised by exfoliation of the skin, excessive sebaceous 
secretion, and formation of a brownish coat of exudate that may cover the 
entire body (Jones, 1956; Underdahl et al., 1965; Devriese, 1977; Jubb et 
al., 1993; Jonsson and Wadstrom, 1993). The organism is less frequently 
found on the skin or in the milk of cattle (Brown et al., 1967) 
- Staphylococcus caseolyticus: It has been reclassified as Micrococcus 
caseolyticus (Kloos et al., 1998). It may be found in milk and dairy 
products (Kloos and Schleifer, 1986). 
- Staphylococcus hominis: Found living on human skin (Kloos and 
Musselwhite, 1975 and Kloos, 1990). Klesser et al. (1998) reported 
infective endocarditis caused by S. hominis after vasectomy. Although it 
is found on human skin, it has also been isolated as a cause of 
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bacteraemia in cancer patients (Bowman et al., 1984). 
- Staphylococcus delphini: It causes purulent skin lesions in dolphins 
(Varaldo et al., 1988). It was also isolated from human abscess by Hind 
Ali (1997) and from sausage (Samia Ismail, 1997). Devriese et al (2005) 
isolated it from clinical and necropsy specimens
 
from a cat, a dog, a horse 
and a parrot. 
- Staphylococcus sciuri: widespread in
 
nature, and they can be isolated 
from a variety of farm animals,
 
pets, and wild animals, as well as from 
various food products
 
of animal origin (Kloos et al.,1997; Garcia et al., 
2002 and  Hauschild et al., 2003). 
- Staphylococcus cohnii: Isolated as normal skin flora (Shleifer and 
Kloos, 1975) and in human skin it produces small and transient 
population (Kloos and Musselwhite, 1975). 
- Staphylococcus xylosus: Schleifer and Kloos (1975) isolated it from 
human skin. Carrillo et al. (2000) described S. xylosus as a coagulase 
negative staphylococcal species that is emerging as a new nosocomial 
pathogen. Also S. xylosus was isolated from animal products such as 
milk, cheese, sausage and so forth. Some times it causes nasal dermatitis 
in gerbils (Solomon et al., 1990) and acute pyelonephritis in humans 
(Tselenis-Kotsowilis et al., 1982). It has also been shown to be associated 
with epizootic fatal dermatitis in athymic nude mice (Bradfield et al., 
1993)  
- Staphylococcus saccharolyticus: An anaerobic species, previously 
called Peptococcus saccharolyticus. Its transfer to the genus 
Staphylococcus was based on oligonucleotide analysis of 16S rRNA 
(Kilpper-Blaz and Schleifer 1981). It is found on human mucous 
membranes. Westblom et al. (1990) reported a single case of endocarditis 
caused by this organism. 
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- Staphylococcus simulans: Found on the skin and in urethras of healthy 
women. S. simulans has been isolated as a cause of septicemia, 
osteomyelitis and septic arthritis following open reduction of fractured 
fibula (Males et al., 1985), as a cause of native valve endocarditis (Jansen 
et al., 1992; McCarthy et al., 1991).  
- Staphylococcus auricularis: This species is found in the human 
external auditory canal, but it is rarely implicated in infections (Kloos and 
wolfsohl, 1983). 
- Staphylococcus carnosus: was isolated from dry sausages (Kloos and 
Schleifer, 1986).  
- Staphylococcus caprae: was originally isolated from goat milk (Poutrel, 
1984 and Nuha Elsayed, 2001). It has been recently found on human skin 
and in human clinical specimens (Kanda et al., 1991). 
- Staphylococcus pulvereri: was isolated from hip infection in human 
(Zakrzewska-Czerwinska et al., 1995). 
- Staphylococcus lugdunensis: Occurs commonly on human skin 
(Herchline and Ayers, 1991). Obeidat (1997) isolated the organism from 
human nose. It causes endocarditis (Walsh and Mounsey, 1990). It has 
also been associated with native and prosthetic valve endocarditis, skin 
and soft tissue cellulites, peritonitis, infected hip prostheses, 
osteomyelitis, vascular line infections and breast abscesses (Freney et al., 
1988; Etienne et al., 1989; Barker et al., 1991; Cormican et al., 1992; 
Vandenesch et al., 1993 and Waghorn, 1994). 
 Staphylococcus simians: was isolated from beef burger (Samia Ismail, 
1997) and from mastitic milk from goat and sheep (Nuha Elsayed, 2001). 
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1.6 Identification and characterization of S. aureus by molecular 
methods 
The use of nucleic acid targets with their high sensitivity and 
specificity may provide an alternative means of accurately identifying 
Staphylococcus species (Drancourt and Raoult, 2002).  
Recently, several investigators have described DNA-based 
techniques for typing strains (Cuny et al., 1996; Gurtler and Barrie, 
1995). Several molecular taxonomic
 
methods, including DNA–DNA 
hybridization and 16S rRNA
 
sequencing, as well as various PCR-based 
techniques, have been reported for the identification and phylogenetic 
study of staphylococci (De Buyser et al., 1992 and Freney et al., 1999). 
The molecular targets have been exploited for the molecular identification 
of Staphylococcus species including: the 16S rRNA gene (Bialkowska-
Hobrzanska et al., 1990 and De Buyser et al., 1992), the tRNA gene 
intergenic spacer (Maes et al., 1997), the heat shock protein 60b (HSP60) 
gene (Goh et al., 1996) and the femA gene (Vannuffel et al., 1999), and 
many other molecualar targets. 
1.6.1 PCR amplification of the thermonuclease (nuc) gene 
Staphylococcus aureus strains produce an extracellular 
thermostable nuclease (thermonuclease or nuc gene) with a frequency 
similar to that at which they produce coagulase (Madison et al., 1983). 
The TNase protein has been well characterized (Thiele, 1990), and its 
gene (nuc gene), has been cloned and sequenced (Kovacevic et al., 1985). 
The TNase is a protein with a molecular mass of 17,000 Da (Tucker et 
al., 1978). It is an endonuclease, degrading both DNA and RNA, and its 
enzymatic activity can resist up to 100 °C for at least 1 hour (Lachica et 
al., 1972). An enzymatic test for TNase production was used in many 
laboratories for the identification of S. aureus isolates (Lachica et al., 
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1971). Brakstad and Maeland (1989) developed a monoclonal antibody-
based sandwich enzyme-linked immunosorbent assay for detection of the 
S. aureus TNase and obtained results which indicated its specificity for S. 
aureus. These results accord with the supposition that the S. aureus 
TNase has species-specific sequence. This supposition was supported by 
the findings of Liebl et al. (1987) who used a 518-bp fragment of the 
cloned S. aureus TNase gene which specifically recognized S. aureus 
strains in a membrane-based DNA hybridization test. 
Brakstad et al. (1992) developed a PCR test based on amplification 
of part the nuc gene for the identification of S. aureus. The nuc primer set 
could recognize all staphylococci identified as S. aureus by conventional 
methods, but not the other bacteria. This nuc-PCR could detect viable S. 
aureus cells or correspondingly low levels (0.69 pg) of extracted DNA in 
saline. The sensitivity of this test accords with that described for PCR 
with other bacteria, being between 1 and 20 CFU (Van Ketel et al., 1990 
and Lebech et al., 1991) and thus it has potential for the rapid diagnosis 
of S. aureus infections by direct testing of clinical specimens, including 
specimens from patients with on going antimicrobial therapy.  
1.6.2 Genetic characterization of Staphylococcus aureus 
1.6.2.1 Staphylococcus catalase (kat) gene 
The main phenotypic differences between S. aureus and S. aureus 
subsp. anaerobius are the weak or negative aerobic growth and the lack 
of catalase activity in the latter (De la Fuente et al., 1985). In S. aureus, a 
correlation between catalase activity and virulence has been observed 
(Mandell, 1975; Kanafani and Martin, 1985), suggesting the role of 
catalase as a defensive mechanism against the oxygen radicals produced 
by macrophages. S. aureus subsp. anaerobius, however,
 
shares with S. 
aureus the ability to produce extracellular toxins
 
and enzymes (De la 
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Fuente and Suarez, 1985; De la Fuente et al., 1985), which traditionally 
have been related
 
to staphylococcal pathogenicity. 
Catalase is a haem- containing enzyme involved in dismutation
 
of 
hydrogen peroxide generated during cellular metabolism to
 
water and 
molecular oxygen. Most of the catalases characterized
 
can be classified 
into one of two types based on their enzymological
 
properties: 
monofunctional or typical catalases, and bifunctional
 
catalase-peroxidases 
(Loewen, 1992). In many bacteria, both
 
types of catalase are present and 
each enzyme is encoded by
 
a different gene (e.g. in Escherichia coli, katE 
and katG code
 
for monofunctional and bifunctional catalases, 
respectively).
 
Monofunctional catalases have been described as proteins 
with
 
molecular masses of approximately 220–350 kDa and are normally 
formed by four identical subunits, each containing
 
one (proto-) haem 
group (Haas and Brehm, 1993). Their active
 
centre and NADPH-binding 
site were described in detail
 
by Fita and Rossmann (1985a, b). 
Comparison of the deduced
 
amino acid sequences of these enzymes 
indicates that typical
 
catalases share regions that are highly conserved 
among microbial,
 
plant and mammalian enzymes (Switala et al., 1990; 
Von Ossowski
 
et al., 1993).
 
 
In S. aureus, a typical catalase with high levels of enzymatic
 
activity and formed of four identical subunits of approximately
 
60 kDa 
has been described (Rupprecht and Schleifer, 1979; Ruiz Santa- Quiteria 
et al., 1992). 
 
Sanz et al. (2000) conducted comparative studies between the 
catalase genes of S. aureus subsp. aureus and S. aureus subsp. 
anaerobius (katA and katB, respectively). They found that katA consists 
of 1518 base pairs open reading frame coding for a protein of 505 amino 
acids, while katB consists of 1583 nucleotides long and encodes for 455 
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a.a. protein. These results showed that katA had undergone mutations, 
which led to generation of katB. These mutations were a deletion of one 
base pair located at
 
1338 bp from the initation codon, in addition to 8 
silent and 6 mis-sense mutations. The deletion resulted in shift of the 
reading frame and premature termination of translation with subsequent 
generation of katB. Four of
  
the 6 mis-sense mutations present in katB 
lead to non-conservative
 
amino acid replacements, the most significant 
being that located
 
at residue 317 (Prolin in katA Serin in katB) because 
the affected
 
amino acid is involved in determining the proximal haem-
binding
 
site. Lack of the catalase activity of S. aureus subsp. anaerobius 
is mainly attributed to these mutations (Sanz et al., 2000). Similarly, loss 
of the catalase enzyme activity in a methicillin resistant S. aureus strain 
was also attributed to mutations of the catalase. These mutations were 
deletion of five successive base pairs, which led to shift in the reading 
frame and premature termination of translation (Grüner et al., 2007). 
1.6.2.2 DNA Polymorphism 
The sequencing of the S. aureus genome indicated the presence of 
several variable number of tandem repeats (VNTR) loci, including coa, 
and spa (Sabat et al., 2003), which have been used for analysis of 
polymorphism and genetic relationship in epidemiological studies. 
1.6.2.3 Staphylocoagulase gene (coa)  
Coagulase is an extracellular protein that binds prothrombin to 
form a complex with thrombin-like activity which coverts fibrinogen to 
fibrin (McDevitt et al., 1992). Coagulase is produced by all strains of S. 
aureus (Kloos and Schleifer, 1986.) and it is a major phenotypic species 
determinant in S. aureus. Its production is the principal criterion used in 
the clinical microbiology laboratory for the identification of S. aureus in 
human infections (Goh et al., 1992), and it is thought to be an important 
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virulence factor (Hookey et al., 1998). Within the encoding gene of coa, 
repeats of 81 nucleotides
 
can be observed, which are clearly polymorphic
 
in both number and sequence (van Belkum et al., 1998). The sizes and 
DNA restriction endonuclease site polymorphisms at the 3´ coding region 
of the coagulase gene have been utilized in PCR-based restriction 
fragment length polymorphism (RFLP) analysis of S. aureus (Hookey et 
al., 1998) and so, typing by PCR-RFLP of this gene can be used to 
monitor relatedness among S. aureus strains (Grzegorczyk et al., 2006). 
Particular PCR products of coa gene were found in some studies of 
approximate lengths of 600, 700, 750 and 800 base pairs (Grzegorczyk et 
al., 2006). 
1.6.2.4 Staphylococcus protein A gene (spa) 
Staphylococcal protein A is a bacterial cell wall product that binds 
immunoglobulin G (IgG) and impairs opsonisation by serum complement 
and phagocytosis by polymorphonuclear leukocytes (Colburn et al., 1980 
and Musher et al., 1981). The decrease of protein A on the cell surface of 
S. aureus results in a greater number of free receptor sites for complement 
C3b and an increase in phagocytosis (Gemmell and O’Dowd, 1983). The 
spa gene is composed of approximately 2,150 bp and harbors a number of 
functionally distinct regions: an Fc-binding region, the so-called X 
region, and, at the C terminus, a sequence required for cell wall 
attachment (Frénay et al., 1994). The repetitive region X of the spa gene 
includes a variable number of 24-bp repeats. The number and sequence of 
individual repeats may differ among strains. Frénay et al. (1994) reported 
that the number of repeats has been related to the dissemination potential 
of S. aureus: strains with more than seven repeats in the X region tended 
to be epidemic, while the presence of seven or less repeats was indicative 
of a non-epidemic methicillin-resistant S. aureus (MRSA) strain. Spa 
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typing has been shown to be an effective and rapid method for typing 
MRSA. Thus, spa typing is used for outbreak investigation, and it may 
prove useful as a practical method for describing a natural population of 
S. aureus organisms (Shopsin et al., 1999 and Moodley et al., 2006). 
1.6.3 Pulsed-field gel electrophoresis 
Pulsed-field gel electrophoresis (PFGE) is based on the whole gene 
by restriction endoneuclease digestion. It was recognized as being one of 
the most discriminatory method for gene typing strains of S. aureus, and 
it has been used to investigate nosocomial outbreaks. PFGE was shown to 
be a useful method for investigating the source, transmission and spread 
of nosocomial infections and for epidemiological typing and 
determination of the genetic relatedness of methicillin resistant S. aureus 
strains (De Lencastre et al., 1996; Lemaitre et al., 1998 and Shimuizu et 
al., 1999). 
1.6.4 Randomly amplified polymorphic DNA (RAPD) 
Randomly amplified polymorphic DNA (RAPD) assays use short 
primers with an arbitrary sequence to amplify genomic DNA in a low-
stringency PCR. These primers randomly hybridize with chromosomal 
sequences that vary among different strains that produce different 
amplification products. These products can be separated by gel 
electrophoresis to produce fingerprints or patterns characteristic of 
different epidemiological types. The method is attractive because it is 
simple to perform and, theoretically, can be applied to any organism 
(Power, 1996).  
The RAPD assay, also called arbitrarily primed PCR, is rapid and 
technically simple (van Belkum et al., 1993 and Tambic et al., 1997).  
It is an effective method for the epidemiological investigation of the 
outbreaks, and performance of typing by this method is simpler and less 
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time-consuming than that of typing by Pulsed-field gel electrophoresis 
(Tambic et al., 1997). 
1.7 Molecular characterization of S. aureus subsp. anaerobius isolates 
from the Sudan 
A recent study in Sudan to compare between local isolates of S. 
aureus subsp. anaerobius has been carried out by El Haj (2002). She 
mentioned that all local isolates were genetically identical; they have the 
same DNA restriction pattern and they almost simulate each other in their 
fatty acids composition, but with regard to protein profiles she reported 
little differences in the number of bands which ranged from 19 to 24, with 
molecular masses ranging from 53.35 to 113.84 kDa. 
1.8 Pathogenicity of Staphylococcus aureus subsp. anaerobius  
1.8.1 Pathogenicity to laboratory animals 
Laboratory animals were found resistant to experimental infection 
by different researchers. Aynaud (1928) found that guinea pigs injected 
intramuscularly or subcutaneously were refractory to experimental 
infection. Also he found mice to be resistant. Joubert (1958) and Shirlaw 
and Ashford (1962) found mice and guinea pigs were refractory to 
experimental infection irrespective of the route or dose administered. De 
la Fuente and Suarez (1985) inoculated four groups of mice 
intraperitoneally or subcutaneously with increasing doses, and by 
intramuscular and intradermal routes. They found that mice are resistant 
to the disease regardless of the dose or inoculation route. Aynaud (1928) 
and Joubert (1958) found rabbits resistant to experimental infection 
through all routes of administration. However, Shirlaw and Ashford 
(1962) obtained cellulitis at the inoculation sites in two out of four rabbits 
from which the organism was recovered in pure culture. Hamad (1989) 
also found the same findings. 
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1.8.2 Pathogenicity to sheep and goats 
Staphylococcus aureus subsp .anaerobius is pathogenic for sheep, 
causing the abscess disease, and experimentally for goats (Aynaud, 1923, 
1927, and 1928). Goats seem to have strong natural resistance to abscess 
disease, although they are sensitive to experimental infection (Aynaud, 
1923, 1927, 1928; El Sanousi et al., 1989). Aynaud (1927) found that the 
organism was pathogenic for sheep and goats when administered by the 
intramuscular, subcutaneous, intraperitoneal and intratesticular routes. 
Abscesses developed at the inoculation sites, but following 
intraperitoneal injection of the organism, abscesses developed in the 
abdominal muscles. The organism is not pathogenic when given by the 
oral or the intratracheal routes (Aynaud, 1927). 
Shirlaw and Ashford (1962) obtained the disease in sheep when the 
organism was administered by the intradermal or subcutaneous routes. 
Abscesses developed after two days on animals infected intradermally 
and after 12 days on those infected subcutaneously. Abscesses were 
observed in adjacent lymph nodes at post-mortem six weeks following 
infection. They noticed that inoculation of the organism into animals by 
scarification did not reproduce the disease in sheep. However, Bajmocy et 
al., (1984) were able to reproduce the disease by scarification, as well as 
by intramuscular and intravenous inoculation. Hamad (1989) observed 
that sheep inoculated with a culture suspension of the organism 
developed a local abscess, which ruptured on the ninth day of inoculation. 
On autopsy seven weeks following infection, he noticed thickening and 
cording of lymphatic vessels from the skin lesion to the adjacent 
prescapular lymph node. Hassan (1996) found that most of the abscesses 
opened by day eight after subcutaneous inoculation of sheep with viable 
S. aureus subsp. anaerobius. Also, he found scarification to cause 
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multiple microabscesses in liver with involvement of mediastinal lymph 
node, but no evidence of abscess formation in the superficial lymph 
nodes.  He noticed that the internal organs of fattened sheep inoculated 
intravenously with viable S. aureus subsp. anaerobius, showed no 
apparent lesions.  
1.9 Vaccination against staphylococcal infections 
There is an increasing need for a safe and effective vaccine to 
prevent staphylococcal infections in the field. In Veterinary practices, live 
staphylococcal vaccines appear to be more effective than killed vaccines 
(Watson and Lee, 1978; Watson, 1987). 
1.9.1 Live Staphylococcus aureus vaccines 
It has been known for many years that live S. aureus vaccines, 
given subcutaneously, provide a considerable degree of protection from 
staphylococcal mastitis (Bridre, 1907 and Derbyshire, 1961). Vaccination 
with live S. aureus vaccine induces a small abscess at the injection site, 
which is grossly and microscopically quite different from the granuloma 
resulting from injection of killed staphylococci (Watson and Kennedy, 
1981). Ruminal neutrophils appear to be membrane receptors for the Fc 
portion of the IgG2 molecules (Watson, 1976). Immunoglobulin G2 is the 
only immunoglobulin isotype, which binds cytophilically to ruminant 
neutrophils (Watson, 1975). Following immunization with live S. aureus 
vaccine, ruminants mount a strong IgG2 anti-S. aureus antibody response 
(Watson, 1987). Recent studies showed that systemic vaccination of 
sheep with a live S. aureus vaccine induced an immune response which 
was characterized by polymorphnuclear neutrophils possessing enhanced 
phagocytic capacity in vitro assay when compared with neutrophils from 
ewes given killed S. aureus vaccine intramuscularly (Watson, 1975, 
1976). Furthermore, results of challenge experiments suggest that live S. 
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aureus vaccines provided stronger protection of the mammary gland than 
killed vaccines when both were administered systemically to sheep 
(Watson and Lee, 1978). However, the problem of reversion to 
pathogenicity, which is common among Staphylococcus species, led to 
lesser use of live vaccines (Ahmed et al., 1990). 
1.9.2 Killed Staphylococcus aureus vaccines 
Killed S. aureus vaccines have generally stimulated long IgG1 but 
poor IgG2 responses and afforded relatively less protection in 
experimental staphylococcal mastitis models (McDowell and Watson, 
1974 and Watson, 1989;). Many attempts at vaccination with bacterins 
and toxoids have been largely ineffective (Anderson, 1978). 
Immunization by the intramammary infusion of antigen during 
pregnancy was partially successful in conferring protection from 
homologous challenge (McDowell and Watson, 1974). Systemic 
administration of killed vaccine proved unsuccessful (Derbyshire, 1962). 
1.9.3 Cellular components as vaccines 
Other potentially protective immunogenic procedures against S. 
aureus infection include the utilization of capsular components, 
particularly polysaccharides (CPS) as vaccines. A few strains of S. aureus 
produce a true capsule (Wilkinson, 1983). However, when growing in 
vivo, S. aureus produces an extracellular glycocalyx comprised largely of 
hydrated polysaccharides (Mayberry-Carson et al., 1984; Speers and 
Nade, 1985). Expression of glycocalyx usually ceases when S. aureus is 
grown in conventional laboratory media and could be lost on subculture 
(Opdebeeck et al., 1987; Sutra et al., 1990).  
Surface polysaccharide capsules formed by pathogenic bacteria are 
important virulence factors, and immunity directed towards capsular 
antigens is often protective (Foster, 1991). Combination of 
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polysaccharide with a protein carrier has been shown to enhance 
immunogenicity and to stimulate a T-cell response (Fattom et al., 1990). 
It has been difficult to study capsules in S. aureus because of poor 
capsule expression when bacteria are grown in conventional laboratory 
media, and because of the tendency of the phenotype to be lost on 
subculture (Rather et al., 1986). This phenomenon was shown in mastitis 
isolates, the majority of which formed diffuse colonies in serum soft agar 
(Yoshida and Ekstedt, 1968). Only 50% of S. aureus strains retained 
diffuse morphology after growth in brain heart infusion medium but more 
than 80% developed diffuse morphology after growth in a high 
carbohydrate medium (Opdebeeck and Norcross, 1983; Yoshida and 
Ekstedt, 1968). Rajab (1997) reported expression of the S. aureus subsp. 
anaerobius capsule in serum charcoal medium developed for that 
purpose.  Some strains of S. aureus permanently form mucoid colonies. 
They form a thick capsule called a macrocapsule, which can be visualized 
by light microscopy with Indian ink staining (Wilkinson, 1983 and Lee et 
al., 1987). Mucoid strains are rarely isolated from human or ruminant 
infections while the most natural isolates form a microcapsule which is 
too thin to be detected by light microscopy (Wilkinson, 1983). The 
macrocapsule associated with mucoid colony morphology is known to 
increase the virulence of S. aureus for laboratory animals (Yoshida and 
Eskstedt, 1968; Koenig and Melly, 1965; Wiley and Maverakis, 1974). 
The enhanced virulence of the mucoid strains is almost certainly due to 
impaired phagocytosis (Wiley and Maverais, 1974; Lee et al., 1988; 
Wilkinson et al., 1979). There is also strong evidence indicating that anti-
capsular polysaccharide (CPS) antibodies promote phagocytosis and 
killing of bacteria with microcapsule (Fattom et al., 1990).  
Adhesion to host cells or to tissue components is an important first 
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step in infection by many pathogenic bacteria. Attachment of bacteria to 
mammary gland epithelial cells appears to be promoted by two surface 
associated proteins (Lindahl et al., 1990). One binds to the glycocalyx 
fibronectin (Forman et al., 1987) which is present on the surface of these 
cells while the other is haemoagglutinin, which promotes binding to 
epithelial cells and to milk fat globules (Lindahl et al., 1990). Several 
pathogenic Gram-positive bacteria express cell-bound proteins, which are 
exposed, on the cell surface. These proteins include protein A (Uhlen et 
al., 1984) and the fibrnectin-binding proteins of S. aureus (Signäs et al., 
1989) and M proteins. These proteins have several features in common 
including an extended structure, a hydrophobic carboxy terminus, a 
proline rich region and surface-exposed repeated domains which interact 
with host proteins (Foster, 1991). 
Protein A is a major component of the cell wall of S. aureus 
(Forsgren et al., 1983). It has five tenderly repeated domains, which bind 
to the Fc region of mammalian IgG (Moks et al., 1986). This interaction 
inhibits phagocytosis in the presence of normal serum (Peterson et al., 
1977) presumably by blocking attachment of opsnins to the macrophage. 
Immunization with protein A might be expected to reverse the inhibition 
of opsonophagocytosis. In this regard, some protection against bovine 
mastitis was obtained with a protein A vaccine (Nickerson et al., 1985), 
whereas passive immunization of infant rats with rabbit anti-protein-A 
serum did not protect against staphylococcal infection (Greenberg et al., 
1989).  
Protection against lethal gangrenous mastitis in rabbits was 
conferred by immunization with a toxoid derivative, but no protection 
was obtained against the chronic form of the disease (Adlam et al., 1977). 
Derbyshire (1960) recorded only a mild transient reaction in the form of 
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neutrophil in the mammary glands of cows vaccinated with a toxin 
preparation after challenge with staphylococci, while non-vaccinated 
cows developed a gangrenous mastitis with complete loss of udder 
function. Aydin and Canbazoglu (1987) vaccinated cows against S. 
aureus mastitis using a bacterin and bacterin toxoid mixture. Bacterin 
(with Aluminum hydroxide) elicited 100% protection for up to six 
months and 50% protection for eight month. The bacterin toxoid mixture 
elicited 50% protection up to the third and sixth months, but no protection 
was obtained during the eight month. Nickerson et al., (1991) evaluated a 
commercially available bacterin that was administered systematically to 
10 cows. Protein A administered in the area of the supramammary lymph 
node was also evaluated in 10 cows, which were boostered every 6 
months and were challenged latter with S. aureus. After three lactation 
trials, there was also reduction in the number of new infections with S. 
aureus in vaccinated animals. However, the number of resolved 
infections was significantly higher in cows vaccinated with the protein-A 
vaccine or a bacterin (83 and 73 percent, respectively) compared with the 
non-vaccinated. 
1.10 Recent specific vaccine trials against Morel’s disease in the 
Sudan 
Rodwan (1996) produced a vaccine containing capsule, whole 
culture and toxoid. Two doses of this vaccine (1.0 ml and 0.5 ml) given 
two weeks a part protected lambs challenged one months later with three 
times the minimum abscess causing dose (Hassan, 1996). 
El Haj (2002) tested three combinations of vaccines: 60% cells 
with 40% toxoid; 50% cells with 50% toxoid and formalized whole 
culture. The culture was cultivated by the IBT bioreactor technology. 
Vaccinated sheep were challenged with S. aureus subsp. anaerobius. She 
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found the best protection when the vaccine constituted 60% cells with 
40% toxoid. Also, she found that the vaccine produced by the IBT 
bioreactor technology was better than the vaccine produced earlier by 
Rodwan (1996). 
1.11 The haemolytic plaque forming cell assay (PFC) 
The direct plaque forming assay was initially developed by Jerne 
and Nordin (1963), and since then has become a mainstay of routine 
cellular immunology research, primarily acsessing humoral IgM antibody 
responses to antigen (Roitt and Delves, 1992). Briefly, B and T lineage 
lymphocyte populations previously presented in vivo with heterologous 
erythrocytes are agar plated in combination with the identical erythrocyte 
suspensions used for immunization. During incubation, the B cells secrete 
IgM antibody to antigenic determinants present on the surface of the 
erythrocytes often with T-cell help, resulting in antibody-erythrocyte 
binding. The presence of an adequate complement source allows 
complement-mediated lysis of the antibody-coated erythrocytes, resulting 
in the formation of clear zones or "plaques" in the agar. Located within 
the centre of each plaque is a single, antibody producing plasma cell. As a 
lytic site can be produced by a single IgM molecule fixing one C1q 
complement molecule, high sensitivity is a major advantage of the PFC 
assay (Smith et al., 1999). In the Sudan PFC was tried for first time by 
Hassan (2001). 
1.12 Opsonophagocytosis 
When the pathogen enters the underlying tissues, the
 
innate 
immune response components including macrophages play
 
a primary 
defence role. Macrophages and other lymphocytes use
 
toxic reactive 
oxygen species (ROS) such as the superoxide anion,
 
hydrogen peroxide 
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and hydroxy radicals to support killing phagocytosed
 
bacteria (Clements 
and Foster, 1999). 
Opsonization, or enhanced attachment, refers to the antibody 
molecules IgG, IgE and the complement proteins C3b and C4b attaching 
antigens to phagocytes. This results in much more efficient phagocytosis. 
Optimal phagocytosis generally requires the presence of complements 
and specific antibodies that recognize the bacterium through Fab regions 
and bind the receptors on the phagocyte (Howard et al., 1980). 
Hyperimmune serum or monoclonal antibodies directed towards surface 
components (e.g., capsular polysaccharide or surface protein adhesins) 
could theoretically prevent bacterial adherence and promote phagocytosis 
by opsonization of bacterial cells. Also, human hyperimmune serum 
could be given to hospital patients before surgery as a form of passive 
immunization (Kenneth Todar University, 2008). 
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CHAPTER TWO 
MATERILAS AND METHODS 
2.1 Survey 
2.1.1 Collection of samples  
One hundred and seventy enlarged superficial lymph nodes were 
taken from sheep at meat inspection in Alkadaro, Ghanawa and 
Alsabaloga slaughter houses. Thirty pus samples were taken from sheep 
affected with abscess disease in outbreak of the disease in a flock of 
sheep at Alsamra village, Khartoum North. Fig. 2 shows the locations of 
these sampling areas in the map of Khartoum State. Pus samples were 
collected from affected lymph nodes as follows: lymph nodes surfaces 
were disinfected with a piece of cotton soaked in 70% alcohol followed 
by hot spatula, small incisions were made using sterile blades, the pus 
was collected aseptically in sterile universal bottles and stored at -20 ºC 
until cultured. Pus from live animals was taken from incised abscess into 
sterile bottles after shaving and disinfection with alcohol. 
2.1.2 Smears 
2.1.2.1 Preparation of smears 
Direct smears were prepared from pus samples in clean glass 
slides, dried, fixed by heating and stained. 
2.1.2.2 Gram’s stain 
Gram's stain was done according to the method described by 
Barrow and Feltham (1993). 
2.1.3 Culture methods 
2.1.3.1 Culturing and purification  
Pus samples were streaked on 10% sheep blood agar plates and 
incubated in candle jars at 37 ºC for 48 h. Subcultures were made for 
further purification of mixed cultures. 
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Fig. 2: Sites of sample collection 
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2.1.3.2. Culture media 
2.1.3.2.1 Solid media 
2.1.3.2.1.1 Blood Agar Base No. 2 (Oxoid), (g/l) 
Proteose Peptone  15  
Liver digest 2.5  
Yeast extract 5  
Sodium chloride 5  
Agar No. 3 12  
pH 7.4 
Forty grams were suspended in one litre of distilled water, steamed 
to dissolve completely and sterilized by autoclaving at 121 ºC for 15 min.  
Defibrinated sheep blood was added to a final concentration of 10% after 
the agar being cooled to 50 ºC, mixed gently and dispensed onto sterile 
Petri-dishes.  
2.1.3.2.1.2 Nutrient agar 
Twenty eight grams of nutrient agar (Oxoid CMR32) were dissolved 
in 1000 ml of distilled water, mixed and sterilized by autoclaving at 
121˚C for 15 min. The medium was then poured into sterile universal 
bottles and set in a slope position to solidify.  
2.1.3.2.1.3 Urea agar base (g/l) 
Peptone  1 
Dextrose  1 
Sodium  Chloride 5 
Disodium Phosphate 1.2 
Potasium Dihydrogen Phosphate 0.8 
Phenol Red 0.012 
Agar no. 3 15g 
pH 6.8  
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An amount of 2.4 g of urea agar base were suspended in 95 ml of 
distilled water, steamed to dissolve completely, sterilized by autoclaving 
at 115 ºC for 20 min and added aseptically  to 5 ml of 40% urea solution 
after cooling to 45 ºC. After being mixed well, the medium was 
distributed into 10 ml sterile MacCarteny bottles and set in a slope 
position to solidify. 
2.1.3.2.1.4 Milk agar 
Oxoid skimmed milk L31 was used. A volume of 50 ml of 10% of 
milk solution was added to 100 ml of nutrient agar, mixed well, sterilized 
at 110 ˚C for 5 min, cooled to 50 ˚C and distributed onto sterile Petri-
dishes in portions of 15 ml each. 
2.1.3.2.2 Liquid medium 
2.1.3.2.2.1 Nutrient Broth 
Thirteen grams of nutrient broth (Oxoid M1) were added to 1000 
ml of distilled water. The medium was distributed into 10 ml in universal 
bottles and then sterilized by autoclaving at 121 ºC for 15 min. 
2.1.3.2.2.2 Brain Heart Infusion (g/l) 
Calf brain infusion solid 12.5  
Beef heart infusion  5.0 
Proteose peptone 10.0  
Glucose 2.0  
Sodium chloride 5.0  
Di-Sodium phosphate 2.5 
pH 7.4 
Thirty seven grams were suspended in one litre of distilled water, 
boiled to dissolve completely and distributed into 20 ml bottles and 
sterilized by autoclaving at 120 ˚C for 15 min. 
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2.1.3.2.2.3 Peptone water (Oxoid) (g\l) 
Peptone 10 
Sodium chloride 5   
pH 7.2  
Fifteen grams were added to one litre of distilled water, mixed 
well, distributed into sterile test tubes and autoclaved at 121 ˚C for 15 
min. 
2.1.3.2.2.4 MR-VP medium (Glucose phosphate medium) 
Five grams of peptone and five grams of K2HPO4 were dissolved in 
1000 ml of distilled water by steaming and filtered; the pH was adjusted 
to 7.5. Five grams of glucose were added; the medium was then 
distributed in 1.5 ml volumes into test tubes and sterilized by autoclaving 
at 110 ºC for 10 min. 
2.1.3.2.2.5 Peptone water sugars 
Peptone water 900 ml 
Andrade’s indicator 10 ml 
The pH of the peptone water was adjusted to 7.1 - 7.3 before 
adding the Andrade’s indicator. Ten grams of the appropriate sugar 
dissolved in 90 ml of distilled water were added to the mixture and mixed 
thoroughly, distributed in five ml portions into sterile test tubes and 
sterilized by autoclaving at 110 ˚C for 10 min. 
2.1.3.2.2.6 Nitrate broth  
KNO3 was dissolved in the broth, distributed in sterile test tubes, 
and sterilized by autoclaving at 115 ˚C for 10 min. 
2.1.3.6 Biochemical tests 
2.1.3.6.1 Aerobic growth  
Test organisms were inoculated on blood agar plates, incubated 
aerobically at 37 ˚C for 48 h and then checked for growth. 
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2.1.3.6.2 Haemolytic activity 
Blood agar plates were inoculated with the test organisms, 
incubated at 37 ˚C for 48 h, put at 4 ˚C for 24 h. The haemolysis was read 
thereafter to perform hot cold haemolysis test. 
2.1.3.6.3 Catalase test 
A drop of 3% aqueous solution of hydrogen peroxide (H2O2) was 
placed on a clean microscopic slide, then with glass or wood loop a 
colony of the test organism was added to it. The test is considered 
positive when gas bubbles appear on the surface. 
2.1.3.6.4 Oxidase test 
Strips of filter papers soaked in 1% solution of tetramethylene-p-
phenylene diamine dihydrochloride were used in this test. Young colonies 
were picked with sterile bent glass rods and rubbed on the filter paper. 
Reactions were considered positive when dark purple colour appeared 
within 5-10 seconds. 
2.1.3.6.5 Colony size and colour 
Milk agar plates containing fresh colonies were placed on the 
bench for overnight at room temperature. The size of a single colony was 
measured, and the colour was noticed. 
2.1.3.6.6 Coagulase slide test 
To detect bound coagulase (clumping factor), a drop of 
physiological saline was placed on a slide. A few colonies were 
emulsified in the drop to make a thick suspension. A drop of undiluted 
human plasma was placed at the end of the slide and then mixed gently 
with the bacterial suspension. Clumping of the organism within 10 
seconds was considered as a positive reaction. 
2.1.3.6.7 Coagulase test 
Equal amounts of diluted human plasma (1% in normal saline) and 
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48 h culture in nutrient broth were mixed carefully, and examined after 1, 
2 and 6 hours. Negative tubes were further incubated overnight and then 
re-examined. 
2.1.3.6.8 Sugar fermentation test 
The ability to ferment seven sugars was tested. The sugars were 
mannitol, maltose, lactose, xylose, trehalose, fructose, mannose, raffinose 
and sucrose. Each isolate was inoculated in a set of the seven sugars. The 
tubes were then incubated and examined for up to 7 days. Change of 
colour to pink indicated positive results. 
2.1.3.6.9 Urease test  
Urea agar slope was heavily inoculated with the test culture and 
then incubated at 37 ˚C for 48 h. Positive reaction was indicated by 
change of colour of the medium to the pinkish. 
2.1.3.6.10 Novobiocin sensitivity test 
The test organisms were spread on the surface of the blood agar 
using a swab. Discs containing 5 µg of novobiocin were applied on the 
plates using sterile forceps. The plates were incubated at 37 ˚C for 24 h. 
Positive results showed a clear zone around the discs. 
2.1.3.6.11 ß-Galactosidase test 
A loop full of colonies was streaked on a filter paper placed into a 
plate and 20 µl of ß-Galactasidase were added to it. The plate was 
covered with aluminium foil and incubated at 37 °C for 1 h.  A volume of 
20 µl of NaOH was added before being read under UV light. Positive 
results were indicated by the development of a fluorescent blue colour. 
2.2 Molecular techniques for characterization of S. aureus subsp. 
anaerobius isolates  
Molecular biology techniques were used to confirm and to compare 
the local isolates with the reference strains. Representative isolates were 
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randomly selected for these tests. 
2.2.1. TBE Buffer (Tris-Borate-EDTA) 10x (pH 8.3) 
Tris base     108 g 
Boric acid     55 g 
Na4EDTA     9.3 g 
ddH2O     1000 ml 
pH 8.3 (without adjustment). 
2.2.2 PCR Master Mix 
Super Hot Master Mix of Bioron (Bioron, Ludwigshafen, 
Germany). This mixture contained: Taq DNA polymerase in reaction 
buffer 0.1 unit/µl, antibodies to Taq DNA Polymerase, (NH4)2SO4 32 
mM, Tris HCl, pH 8.8 at 25 °C, 130 mM, 0.2% Tween 20, MgCl2 3mM 
and dNTP (dATP, dCTP, dGTP, dTTP) 0.4 mM of each. 
2.2.3 Agarose gel (2%) 
For small size gels, 2.4g of agarose were added to 120 ml of 1x 
TBE buffer; heated in microwave to melt, mixed well before addition of 
50 µl of ethidium bromide; the mixture was poured into the appropriate 
plate and left to solidify after insertion of the appropriate comb. 
2.2.4 Isolates for the molecular characterization 
Twenty two isolates of S. aureus subsp. anaerobius (Table 1) 
obtained from lymph node abscesses of sheep at different 3 areas (7 from 
outbreak of sheep abscess in Alsamra village, 9 from Alkadaro slaughter 
house and 6 from Ghanawa slaughter house).  
2.2.5 DNA extraction 
Genomic DNA was extracted using Axy Prep Bacterial Genomic 
DNA Miniprep Kit of Axygen (Bioron, Ludwigshafen, Germany) with 
some modifications of the manufacturer’s protocol: 
- 3-5 colonies of S. aureus subsp. anaerobius obtained from 48 h blood 
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agar culture were suspended in 150 µl of the recommended buffer (after 
adding the RNase). 
- 10 l of Lysostaphin (Sigma, Taufkirchen, Germany) 1mg/ml were 
added to the mixture and incubated at 37 °C for 1 h. 
- 2 l of 10% Proteinase K (Bioron) was added and incubated at 56 °C for 
2 h. 
2.2.6 DNA concentration 
For all samples, the DNA concentration was measured by a 
spectrophotometer (Nanodrop ND1000, Peqlab, Erlangen, Germany). 
2.2.7 Purification of the PCR products for sequencing 
Montage PCR Centrifugal Filter Devices (Millipore, Bedford, 
USA) were used to purify PCR products prior to sequencing. 
2.2.8 Primers 
Primers used in this part are listed in table (2). All primers were 
synthesised by ThermoFisher Scientific, Germany (Thermo Electron, 
Oberhausen, Germany). 
2.2.9 PCR reaction mixture  
For 25 l PCR reaction mixture, the following were mixed: 
Master Mix    12.5 µ 
Primer 1    0.5 µ 
Primer 2    0.5 µ  
ddH2O    11.5 µ 
A volume of 23 µl of the PCR mixture was added to 2 µ of the 
DNA template. 
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Table 1: Staphylococcus aureus subsp. anaerobius used in this study 
No. Code Source 
1 K1 Alkadaro slaughterhouse 
2 K8 Alkadaro slaughterhouse 
3 K10 Alkadaro slaughterhouse 
4 K11 Alkadaro slaughterhouse 
5 K17 Alkadaro slaughterhouse 
6 K18 Alkadaro slaughterhouse 
7 K22 Alkadaro slaughterhouse 
8 K41 Alkadaro slaughterhouse 
9 G2 Ghanawa slaughterhouse 
10 G35 Ghanawa slaughterhouse 
11 G40 Ghanawa slaughterhouse 
12 G42 Ghanawa slaughterhouse 
13 G58 Ghanawa slaughterhouse 
14 G97 Ghanawa slaughterhouse 
15 S7 outbreak in Alsamra village 
16 S8 outbreak in Alsamra village 
17 S9 outbreak in Alsamra village 
18 S10 outbreak in Alsamra village 
19 S14 outbreak in Alsamra village  
20 S16 outbreak in Alsamra village 
21 S18 outbreak in Alsamra village 
22 S19 outbreak in Alsamra village 
23 Reference strain ATCC35844, DSM no. 20714* 
24 Reference strain IBT Culture Collection Göttingen 
no.9199/2628 
*DSM: Deutsche Sammlung von Microorganismen und Zelkulturen, 
Braunschweig, Germany. 
38 
 
Table 2: Oligonucleotides used in this study 
Primer 
name  
Sequence Reference 
nuc 1 5´GCGATTGATGGTGATACGGTT 3´ Brakstad et al. (1992) 
nuc 2 5´AGCCAAGCCTTGACGAACTAAAGC 3´ Brakstad et al. (1992) 
3 F 5  ´GCTTTTTAAGTGTACTATTC 3´ This study 
164 F 5  ´TATAAATTGTGGAGGGATGAC 3´ Sanz et al. (2000) 
808 F 5  ´CTCCATTTTAGAACGCAACAA 3´ Sanz et al. (2000) 
1396 F 5  ´GATGGATACGGCTATGAATA 3´ This study 
872 R 5  ´GCTATAATTTCAGCAGCTTC  3´ This study 
1583 R 5  ´TGGGTCAGCTTTGTAACA 3´ Sanz et al. (2000) 
1726 R 5  ´TCATAAACTGCTCAACTACGC 3´ Sanz et al. (2000) 
786 5´GCGATCCCCA 3´ Pereira etal.(2002) 
798 5  ´TGACCCGCC 3´ Pereira etal.(2002) 
spa 1 5  ´CAAGCACCAAAAGAGGAA 3´ Frénay et al. (1994) 
spa 2 5  ´CACCAGGTTTAACGACAT 3´ Frénay et al. (1994) 
coa 1 5  ´CGAGACCAAGATTCAACAAG 3´ Goh et al. (1992) 
coa 2 5  ´AAAGAAAACCACTCACATCA 3´ Goh et al. (1992) 
 
 
 
 
39 
 
2.2.10 PCR reaction conditions  
PCR reaction conditions used for the amplification of different 
genes targeted in this study are shown in Table 3. 
 
Table 3: PCR thermocycler protocols used in this study 
Step/  Nuclease Catalase RAPD Polymorphism 
Protocol °C min °C min °C min °C min 
First 94 5 94 10 - - - - 
Denaturation 94 1 94 1 94 1 95 0.5 
Annealing 55 0.5 52 1 36 1 55 2 
Extension 72 1.5 72 1.5 72 2 72 4 
Final 72 3.5 72 10 72 7 72 5 
Cycles 37 30 30 40 
 
2.2.11 Gel documentation 
PCR-amplification products were subjected to electrophoresis in 
agarose gel (section 2.2.2) in lx TBE buffer using horizontal electro-
phoresis system (Power N PAC 3000, BioRad, Munich, Germany). PCR 
products (18 or 9 μl) were mixed with 1 or 2 l of bromphenol blue stain 
before being applied to wells. Seven µl of the molecular weight standard 
(λ DNA-Hind III/ФXHae III (Finnzymes, Espoo, Finland) was included 
in each gel. One hundred constant volts were applied to the gels for 1 h. 
DNA amplified segments were visualized by UV illuminator (MWG, 
Ebersberg, Germany) connected to a PC and a monitor. 
40 
 
2.2.12 nuc gene detection 
PCR amplification of the nuclease (nuc) gene was done so as to 
confirm the biochemical identification of the isolates as S. aureus. The 
primers designed by Brakstad et al. (1992) were used for this purpose 
(Table 2). 
2.2.13 Catalase gene (kat gene) 
2.2.13.1 Amplification of the catalase gene (kat gene)  
Many segments of the catalase gene were amplified using many 
sets of primers (Table 2). The primers were designed in this study based 
on the sequences of the catalase genes of S. aureus strain MVF213 
(GenBank accession no. AJ000471) and S. aureus strain ATCC12600 
(GenBank accession no. AJ000472).  
2.2.13.2 Sequencing of the catalase gene 
PCR amplification products of some segments of the catalase gene 
were sequenced in this part. Sequencing of the whole catalase gene of 
isolate S10 was achieved by partial sequencing using sets of primers as 
follows: 808F and 1583R; 164F and 1396R; 1396F and 1726 R; 3F and 
872R. Partial sequencing of about 990 bp of other five (K22, K41, G2, 
G35 and S19), and about 700 bp of three (K1, G97 and S7) local isolates 
in addition to one reference strain (ATCC35844, DSM no. 20714) was 
done using primer 1583R. 
Purified PCR products plus the diluted primers (10 pM) were sent 
to in a commercial company (SeqLab, Göttingen, Germany) in an ABI 
sequencer. 
2.2.13.3 Sequence alignment and editing 
The sequences of the PCR products were edited by BioEdit 
Sequence Alignment Editor, version 7.05.3 (10/28/05). 
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2.2.14 RAPD-PCR 
Randomly amplified polymorphic DNA PCR (RAPD) was used to 
detect possible differences between the strains. Two primers (786 and 
798) designed by Pereira et al. (2002) were used (Table 2). Amplification 
conditions are shown in Table 3.  
2.2.14.1 RAPD optimization (Confirmatory test for MgCl2) 
When the PCR reaction mixture mentioned by Pereira et al. (2002) 
was used, no clear amplicons were seen. So, two additional MgCl2 
concentrations (4.5 mM, and 6 mM) in the PCR reaction mixture were 
evaluated. 
2.2.15 Pulsed-field gel electrophoresis (PFGE) 
2.2.15.1 Buffers 
2.2.15.1.1 Lysis buffer, pH 7.6 
Tris     6 mM 
NaCl     1 mM 
EDTA    10 mM. 
Brij-58    5 g. 
Sodium deoxycholate  2 g. 
Sodium lauroylsarcosine  5 g. 
Lysozyme    5 g. 
Lysostaphin    5000 units 
dd H2O    1000 ml 
2.2.15.1.2 Washing buffer (Tris - EDTA), pH 8.0 
TrisHCl   10 mM 
EDTA   1 mM 
dd H2O   1000 ml 
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2.2.15.2 PFGE Protocol 
-Overnight cultures of bacterial cells were harvested and resuspended in 
10 mM Tris-EDTA after washing in TE buffer (l0 mM Tris-HCl, 50 mM 
EDTA; pH 7.5).  
- The bacterial suspension was adjusted to a concentration of 1x10
9
 
cfu/ml by using Mc Farland tube No. 4 turbidity. 
-200 µl of the bacterial suspension was added to an equal volume of 2% 
low-melting point agarose, 6 µl of lysostaphin were added and mixed 
well before being allowed to solidify in a plug mold (Bio-Rad).  
-Each agarose block was removed from the mold and suspended in the 
lysis solution. The bacterial cells were lysed by subsequent incubation of 
the blocks in 100 µl lysis buffer at 37 °C for 6 h. 
-The gel plugs were incubated overnight at 55 °C in 2 ml of proteinase K 
(10 mg/ ml), with gentle shaking.  
-The plugs were washed 3 times with a cold TE buffer for 20 minutes. 
Slices of the plug were cut and digested with 40 U of restriction 
endonuclease SmaI (Bioron) in the recommended restriction enzyme 
buffer (supplied by the manufacturer) and incubated overnight at 30 °C. 
-The plugs were then loaded into 1% agarose gel wells, and sealed with 
2% low-melting point agarose. 
-The contourclamped homogeneous electric field apparatus from Bio-Rad 
was used to separate the DNA fragments. 
-The gel was subjected to electrophoresis for 24 h at 15 °C with a voltage 
of 175 V and pulse times of 15 to 30 s in 0.05 M Tris-borate-EDTA 
buffer.  
-The pulse times used were 5 s to 15 s for 8 h followed by 15 s to 25 s for 
10 h.  
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-The gel was then visualized and photographed using a UV Trans-
illuminator (MWG, Esberg, Germany) connected to a PC and a monitor. 
2.3 Animal experiments  
2.3.1 Pathogenecity of S. aureus subsp. anaerobius 
Blood agar culture of S. aureus subsp. anaerobius was inoculated 
in brain heart infusion broth and incubated at 37 °C for 48 h. The culture 
was counted according to Miles and Misra (1938), and different dilutions 
were made. 
Each of five Hamari lambs (about 10 months old) was inoculated 
with six different doses of the organism as shown in Table 4. The 
inoculums were injected subcutaneously after shaving and proper 
disinfection. 
Table 4: Number of the inoculated organisms per lamb for pathogenecity 
test 
Dose no. No. of organisms (CFU) Site of inoculation 
1 480  Right (upper neck) 
2 2400  Right (middle neck) 
3 4800  Right (lower neck) 
4 24000  Left (upper neck) 
5 48000  Left (middle neck) 
6 480000  Left (lower neck) 
 
2.3.2 Pathogenecity of other staphylococci 
I) Five 8-12 months old Hamary male sheep were kept for 15 days as 
adaptation period, during which they were given doses of anthelmentics 
and antibiotics. Each of five different Staphylococcus species (S. aureus 
subsp. anaerobius, S. aureus, S. caseolyticus, S. lugdenensis and S. 
simians), which were isolated in this study, was inoculated in one animal. 
Blood agar cultures of the organisms were inoculated into Brain Heart 
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Infusion broth, incubated at 37 °C for 48 h before being inoculated to the 
animals. Each animal was noculated with 1200 cfu of each organism in 
right middle of the neck after shaving, cleaning with cotton soaked in 
70% alcohol and drying with sterile gauze. 
II) Each of other four animals, prepared as mentioned above, was 
inoculated using one mixture of two isolates:  
-S. aureus subsp. anaerobius + S. aureus 
-S. aureus subsp. anaerobius +S. caseolyticus, 
-S. aureus subsp. anaerobius +S. lugdenensis 
-S. aureus subsp. anaerobius + S. simians 
A fifth ram was inoculated with S. aureus subsp. anaerobius alone 
as control. 
2.3.3 Vaccination and challenge 
2.3.3.1 The vaccine 
The vaccine used in this study was originally prepared by Rodwan 
(1996). It was prepared from broth cultures of S. aureus subsp. 
anaerobius supplemented with 2% horse serum. The cultures were 
incubated under anaerobic conditions, at 37 °C for 48-72 h. The media 
were constantly adjusted to pH 7.2. 
2.3.3.1.2 Ingredients of the vaccine 
The vaccine consisted of the following mixtures of antigens: 
 (i) Whole formalinized culture. 
 (ii) Toxoid. 
 (iii) Capsule. 
These components were prepared by the following procedures: 
(i) Toxoid 
The supernatant of broth cultures (on brain heart infusion broth and 
RCM) of S. aureus subsp. anaerobius (Isolate no. 11) were filtered 
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through a 0.4 µm Seitz filter and then concentrated twice using 
polyethylene glycol; pH of the concentrated toxin was adjusted to 7.0; 
formaline was added to a final concentration of 0.5% (v/v) to inactivate 
the toxin. 
(ii) Capsular antigen 
The capsular antigen was prepared by culturing S. aureus subsp. 
anaerobius on a special solid medium containing peptone, beef and yeast 
extracts, Na, Mn, K, salts in addition to horse serum, glucose and 
charcoal according to Rajab (1997). 
The vaccine strain of the organism was cultured on this medium, 
incubated in 10% CO2 tension at 37 °C for 24 h. Cultures were 
subsequently washed with 4 ml of 1% phenol and then kept at 4 °C for at 
least two weeks before use. 
2.3.3.1.3 Mixing different ingredients of the vaccine 
Thirty millilitres of the double concentrated toxoid were added to 
45 ml of formalinized 48 h culture in brain heart infusion broth, pH of the 
mixture was adjusted to pH 7.0, 25 ml of the medium containing capsule 
were added. All ingredients were added while gentlely shaking; the pH 
was maintained at pH 7.0. Formaldehyde was added to a final 
concentration of 0.5 % v/v. The final vaccine was further diluted by 
addition of 75% of the mixture and 25% sterile normal saline. 
2.3.3.2 Evaluation of the effective dose of the vaccine 
2.3.3.2.1 Titration of the vaccine 
Eighteen, 8-12 months old, Hamari male sheep were purchased 
from the local market. The animals were kept for adaptation period, 
during which they were given prophylactic doses of anthilmentics, and 
antibiotics and were sprayed with acaricides. The animals were divided 
into 6 groups. Each one of the 5 groups received a different dose of the 
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vaccine, while the sixth group served as a control non-vaccinated. The 
vaccine was diluted with sterile normal saline and completed to one 
millilitre as shown in Table 5. The doses were 0.25, 0.75, 0.5, 1 and 0.5 
m. The last group received a booster dose of another 0.25 ml after 2 
weeks. The vaccine doses were injected subcutaeonusly at the right side 
in the middle crest of the neck after shaving. The sites of injection were 
examined daily for up to 21 days and the rectal temperature was recorded, 
whole blood for haemogram was collected weekly. Injection sites of the 
vaccine and challenge were examined daily and palpated for post-
vaccinal tissue reaction.  
2.3.3.2.2 Challenge 
After 21 days, animals of all groups (the previous section) were 
challenged with 1200 cfu of S. aureus subsp. anaerobius as in section 
2.3.1. The sites of inoculation were examined daily for up to 14 days for 
development of abscesses. Rectal temperature was recorded. Whole blood 
for haemogram was collected weekly. The diameter of the inoculation 
sites were recorded in mm. Pus samples were collected from the 
discharging abscesses in sterile containers and cultured in the same day 
on blood agar. 
Table 5: Vaccination trials of groups of sheep with different doses of the 
vaccine against Morel’s disease 
Group A B C D E Control 
Dose of vaccine (ml) 
 
0.25 
 
0.50 
 
0.75 
 
1.00 
initial booster  
0 0.50 0.25 
Diluent (Sterile 
Normal Saline), ml 
0.75 0.50 0.25 0 0.50 0.75 1.0 
Total (ml) 1.0 1.0 1.0 1.0 1.0 1.0 1.0 
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2.3.3.2.2 Evaluation of the vaccine against different staphylococci 
This experiment was conducted to evaluate the ability of Morel’s 
disease vaccine to protect against abscess formation caused other 
staphylococci. 
2.3.3.2.2.1 Vaccination and challenge with one Staphylococcus species 
Five, 8-12 months old male Hamary sheep were kept for adaptation 
period of one week after receiving prophylactic doses of anthilmentic, 
antibiotic and being sprayed with acaricides. The animals were 
vaccinated with 0.5 ml of the vaccine and boostered after 15 days with 
0.25 ml. 
The sheep were challenged after one month from the first dose of 
the vaccine with 4,800 cfu of one species of staphylococci isolated in this 
study. Animals were daily examined for up to 21 days.  
2.3.3.2.2.2 Vaccination and challenge with two Staphylococcus species 
Ten 8-12 months old Hamary male sheep were kept for a period of 
adaptation of one week after being given prophylactic doses of 
anthilmentic, antibiotic and sprayed with acaricide. All animals were 
vaccinated with 0.5 ml of the vaccine and boostered after 15 days using 
0.25 ml. The animals were divided into two groups; each group was 
challenged- one month after vaccination- with a mixture of S. aureus 
subsp. anaerobius (1200 cfu) and 0.5 of neat culture (about 2,400,000 
cfu) of either of S. aureus and S. caseolyticus. Two animals of each group 
received one species as control.  
2.3.3.2.2.3 Post-mortem examination 
All animals were slaughtered three weeks after challenge. 
Macroscopic findings were recorded in control sheets. Samples were 
taken for both bacteriology and histopathology in addition to impression 
smears. One spleen from each group was taken for plaque forming cell 
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assay test.  
2.6 Immunological tests 
2.6.1 Plaque forming cell assay 
2.6.1.1 Preparation of the antigen 
Sheep blood was collected in Alsever’s solution (10%). The red 
blood cells (RBCs) were washed 3 times with phosphate buffer saline 
(PBS), pH 7.4. Equivalent volumes of 10% RBCs and tannic acid 
solution (5 mg tannic acid in 100 ml PBS) were mixed and incubated at 
37 °C for 20 min. The Ag (vaccine) was dissolved in PBS pH 6.4 at 
concentration of 0.2-mg/ ml. Equivalent volumes of Ag, with tanned 
sheep RBCs were mixed well and incubated at 37°C for 20 minutes. The 
combination was then washed three times in normal saline containing 
0.5% heat inactivated normal rabbit serum (at 56°C). 
2.6.1.1.2 Sheep red blood cells (SRBCs) 
Sheep blood was washed twice in Phosphate Buffered Saline (PBS) 
and once in Balanced Salt Solution (BSS)- “Hank’s Solution”-, then the 
blood was diluted to 1 in 3 with BSS. RBCs were washed three times 
with PBS and then re-suspended as 20% volumes. 
2.6.1.1.3 Effector cells 
The splenic cells were collected from the four groups of sheep: 
before vaccination, one week after vaccination, two weeks after 
vaccination and one week after the booster dose of the vaccine. The cells 
were washed three times in BSS and re-suspended as 10% in BSS  
2.6.1.1.4 Agarose 
The agarose was dissolved in BSS at 0.5% in a 100 °C water bath 
and then held at 47 °C until used. 
2.6.1.1. 5 Complement 
Freeze-dried Guinea pig serum (Wellcome, UK) was used as 
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complement source. The contents were reconstituted in 2 ml sterile 
distilled water and then diluted to 1 in 3 with BSS. 
2.6.1.1.6 Balanced Salt Solution (BSS) 
The following ingredients were dissolved: 
Phenol     10 mg 
CaCl2      140 mg 
NaCl      800 mg 
KCl      100 mg 
MgSO4.7H2O    200 mg 
MgCl2.6H2O    200 mg 
The salts were added to one litre of distilled water, the pH was 
adjusted to 7.0-7.2 and the solution was stored at -20 °C until used.  
2.6.1.2 Plaque forming cell assay mixture 
Small test tubes were placed in 47 °C water bath; to each tube the 
following items were added: 
Agarose         300  μl 
RBCs         20 μl 
Spleen cell suspension       100 μl 
Complement (dil. 1:3, added while whirl mixing)  40 μl 
All components were mixed rapidly on a whirl-mixer, poured on a 
slide and allowed to set. The slides were incubated at 37 °C in humidity 
chamber, examined after one hour by the naked eye and low power lens 
of the microscope (10x) and also after overnight incubation. 
2.6.1.2 Validity of spleen cells  
Viable spleen cells count was done every day untill all cells were 
dead, using trypan blue staining method. The cells were stored in either 
RPMI; Histopaque solution or were left without storage solution. 
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2.6.2 Opsonophagcytosis tests 
Phagocytosis of S. aureus by ovine polymorphnuclear cells 
(neutrophils) in the presence or absence of opsonin was measured using a 
modification of the method of Verhoef et al. (1977) as below. 
2.6.2.1 Bacterial growth 
S. aureus subsp. anaerobius were grown in 5 ml nutrient broth at 
37 °C for 48 h and used at a concentration equivalent to McFarland’s 
opacity tube No. 4, which is equivalent to 1.2 X 10
9
 cell/ml, according to 
Baron et al. (1994).  
2.6.2.2 Blood samples 
Fresh sheep blood was collected from the jugular vein of healthy 
sheep using sodium citrate as anticoagulant. A volume of 0.9 ml of sterile 
PBS was pipetted into each of four test tubes under aseptic conditions; 
0.1 ml S. aureus subsp. anaerobius culture was added to the first tube and 
serially diluted. Dilution 1/1000 was used in this test. 
2.6.2.3 Opsonization method 
The test was performed in three eppendorf tubes. In the first tube 
0.2 ml of the diluted culture of S. aureus subsp. anaerobius was added to 
0.1 ml of the vaccinated sheep serum; in the second eppendorf tube 0.2 
ml of the diluted culture of S. aureus and 0.1 ml normal sheep serum; the 
third and fourth eppendorf tubes served as controls containing 0.2 ml of 
diluted cultures (S. aureus or S. aureus subsp. anaerobius) and 0.6 ml 
sheep blood. The tubes were incubated for 30 min with mixing every 10 
min. After incubation, 0.5 ml of fresh sheep blood was added to each 
tube.  
Phagocytosis assay was carried out by incubation of the eppendorf 
tubes at 37 °C with frequent mixing for 1 h. One ml of the mixture of 
each tube was then inoculated subcutaneously into experimental animals 
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(Hamary sheep) at 0 and 120 min and spread at the same time on blood 
agar plates by dropping 10 μl into blood agar plates. Each experiment was 
done in duplicates. The plates were incubated at 37 °C for 24 h under 
10% increased CO2 tension, growing colonies were counted. 
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CHAPTER THREE 
RESULTS 
3.1 Survey for sheep abscess disease 
3.1.1 Isolates from lymph nodes of animals at meat inspection 
From 170 pus samples of infected lymph nodes collected from 
sheep at meat inspection at Alkadaro, Ghanawa and Alsabaloga slaughter 
houses, 117 (68.8%) were Staphylococcus spp., 45 (26.5%) 
Corynebacterium spp. and 8 samples (4.7%) yielded both Staphylococcus 
spp. and Corynebacterium spp. Fig. 3. 
Staphylococcus aureus subsp. anaerobius was the most prevalent 
among staphylococci isolates (63.2%) followed by S. caseolyticus 
(21.3%), S. aureus (11.9%) and S. simians, S. lugdunensis, S. warneri, S. 
epidermidis (each 0.9%)  as shown in Fig. 4 and Table 6. 
3.1.2 Isolates from outbreak of sheep abscess disease 
The outbreak occurred in a flock of sheep in Alsamra village in 
Khartoum State. The animals were freely raised in natural grazing area 
during the day and they used to reside to pen in the evenings, where they 
received some type of feed supplementation. The morbidity among herd 
was 30%. Two females were infected and lambs of about 2 months of age 
were also infected. The commonly infected lymph nodes were 
prescapular, parotid and submandibular (Fig. 5). From 28 animals 
(93.3%) of the pus samples yielded pure cultures of S. aureus subsp. 
anaerobius, while the rest two animals (6.7%) yielded Corynebacterium 
spp. 
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Fig. 3: Bacteria isolated from superficial lymph abscess of sheep at meat 
inspection 
 
 
Fig. 4: Staphylococcus spp. isolated from superficial lymph node 
abscesses of sheep at meat inspection 
63 % 
12 % 
21 % 
1 % 
1 % 
1 % 
1 % 
Staphylococcus aureus  
subsp. anaerobius 
S. aureus 
S. caseolyticus 
S. simians 
S. lugdunensis 
S. warneri 
S. epidermidis 
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Fig. 5: Sheep flock in Alsamra village, Khartoum North, Sudan, 
in which outbreak of abscess disease occurred. A, C, abscesses in 
the parotid lymph node; B, abscesses in the parotid and 
submandibular lymph nodes; D, abscesses in the parotid and 
prescapular lymph nodes; E: part of the flock in natural grazing 
area. 
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Table 6: Staphylococcus species isolated from infected superficial lymph 
nodes anscesses of sheep at meat inspection in Alkadaro, Ghanawa and 
Alsabaloga slaughter houses in Khartoum State 
No. Staphylococcus spp. Total no. % 
1 S. aureus subsp. anaerobius 74 63.2 
2 S. caseolyticus* 25 21.3 
3 S. aureus 14 11.9 
4 S. simians 1 0.9 
5 S. lugdunensis 1 0.9 
6 S. warneri 1 0.9 
7 S. epidermidis 1 0.9 
* Staphylococcus caseolyticus has been renamed Macrococcus caseolyticus 
 
3.2 Properties of staphylococci isolated from sheep abscesses 
All isolates grew well under anaerobic conditions after 48 h 
incubation at 37 °C. S. aureus subsp. anaerobius colonies were smooth, 
glistening, convex, about 1 mm in diameter (Fig. 6). Colony properties of 
other staphylococci are shown in Table 7. 
 
Table 7: Colonial morphology of staphylococci isolated from superficial 
lymoh node abscesses of sheep 
No. Staphylococcus spp. Total no. % 
1 S. aureus subsp. anaerobius 74 63.2 
2 S. caseolyticus* 25 21.3 
3 S. aureus 14 11.9 
4 S. simians 1 0.9 
5 S. lugdunensis 1 0.9 
6 S. warneri 1 0.9 
7 S. epidermidis 1 0.9 
* Staphylococcus caseolyticus has been renamed Macrococcus caseolyticus 
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Fig 6: Staphylococcus aureus subsp. anaerobius colonies grown on blood 
agar medium. 
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3.3 Biochemical properties 
The biochemical properties of bacteria isolated in this study are 
shown in Tables 8 and 9.  
All S. aureus subsp. anaerobius isolates were anaerobic, 95% grew 
as pin point colonies after 4-5 days of aerobic incubation, all were 
haemolytic; catalase, oxidase, manniol, and B-galactosidase negative; all 
were positive for the clumping factor and coagulase. 
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Table 8: Biochemical properties of staphylococci isolated from lymph 
node abscesses of sheep at meat inspection and with Morel’s Disease 
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Table 8: continued 
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Table 8: continued  
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Table 9: Biochemical properties of Staphylococcus aureus subsp. 
anaerobius isolated in this study 
No. Test 
No. of 
positive 
isolates 
No. of 
negative 
isolates 
No. of 
doubtful 
isolates 
1 
Anaerobic 
growth 
74 - - 
2 Aerobic growth
1
 - 4 70 
3 Haemolysis
2
 74 - - 
4 Oxidase - 74 - 
5 Catalase 74 - - 
6 Coagulase
3
 74 -  
7 Mannitol 
(anaerobic) 
- 74 - 
8 ß- galactosidase - 74 - 
9 Clumping factor 74 - - 
10 VP - 72 2 
1: very small colonies after 4-5 days, 2: double zoon, hot cold 
haemolysis, 3: after 1 hour and also after 24 overnight incubation. 
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3.9 Molecular biology results 
3.9.1 DNA concentrations 
DNA concentrations extracted from the isolates used in molecular 
characterization are shown in Table 12.  
Table 10: DNA concentrations of S. aureus subsp. anaerobius isolates 
used in the part of molecular characterization 
No. Isolate code DNA concentration (ng/µl) 
1 K1 3.6 
2 K8 6.3 
3 K10 2.3 
4 K11 2.9 
5 K17 2.1 
6 K18 1.6 
7 K22 1.1 
8 K41 0.7 
9 G2 0.8 
10 G35 1.2 
11 G40 1.4 
12 G42 2.3 
13 G58 2.4 
14 G97 1.4 
15 S7 2.7 
16 S8 3.1 
17 S9 3.0 
18 S10 3.0 
19 S14 7.3 
20 S16 2.3 
21 S18 8.9 
22 S19 15.5 
23 Reference strain ATCC35844, 
DSM no. 20714 
4.2 
24 Reference strain IBT-Göttingen 
Culture Collection No. 9199/2628 
1.3 
DSM: Deutsche Sammlung von Zellkulturen und Mikroorganismen 
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3.9.2 Nuc gene detection 
All S. aureus subsp. anaerobius isolates yielded amplicons of the 
nuc gene as shown in Fig.7. 
3.9.3 Catalase gene (kat gene) 
3.9.3.1 Detection of the catalase gene  
All S. aureus subsp. anaerobius isolates yielded positive 
amplification results of the catalase gene. Amplicons of the catalase gene 
using different sets of primers are shown in Figs. 8, 9 and 10.  
3.9.3.2 Sequencing results of the catalase gene 
The complete sequence of the catalase gene of S10, isolated from 
the outbreak in Alsamra village, is shown in Table 11 and Appendix 1. 
The whole amplified part of the putative catalase gene of strain S10 
(katS10) was 1725 nucleotides in length. The open reading frame starts at 
base 164 (ATG, the initiation codon), and ends at base 1999 (TGA, the 
stop codon). This sequence was deposited in the GenBank under 
accession no. EU281993 (Appendix 2). 
Catalase gene sequence of S. aureus subsp. anaerobius strain S10 
(outbreak isolate) showed 99% identity to that of S. aureus subsp. 
anaerobius MVF213 (GenBank accession no. AJ000471), S. aureus 
subsp. aureus NCTC8325, S. aureus subsp. aureus strain Newman 
(GenBank accession nos.CP000253 and AP00935.1, respectively) as 
shown in Appendices 2 and 3. 
Comparison of this sequence with the sequence of katB (the 
catalase-like protein of S. aureus subsp. anaerobius MVF214) revealed 
mismatches of only three bases, but in comparison with katA gene 
sequence of S. aureus subsp. aureus strains (NCTC 8325 and strain 
Newman), 15 bases substitutions occurred within the coding region for 
katA, six of which were mis-sense mutations while the others were silent 
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mutations (Fig. 11, Tables 12 and 13). The substitution occurred at 
position no. 1099 of katS10 gene from “C”, in katA and katB genes to “T” 
resulted in a stop codon.  The predicted protein encoded by katS10 is 345 
amino acids in length (Appendix 4). 
The partial sequence of the catalase gene of other two isolates from 
the same disease outbreak in Alsamra village (S7, S19) in addition to 3 
isolates from each of Ghanawa (G1, G11) and Alkadaro (K1, K35) 
slaughter houses were 100% identical to that of the corresponding region 
of katS10. 
The partial sequence of the refrence strain, S. aureus subsp. 
anaerobius ATCC35844, DSM no. 20714, was 100% identical to that of 
MVF213. 
 The sequence results of the other nine strains: K41, S19, G2 and 
the reference strain are shown in Appendices 6, 7, 8 and 9, respectively. 
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MW  G2 G35 G40 G97 k10 k11 k17 k18 k22 k41 S9 S10 S14 S16S18S19Ref
1
-ve    
 
Fig. 7: a and b, agarose gel (2%) electrophoresis results of amplification 
of the nuc gene of S. aureus subsp. anaerobius isolates. 
G2, G35, etc…, isolates obtained from Ghanawa Slaughter House 
K1, K2, etc…, isolates obtained from Alkadaro Slaughter House 
S7, S8, etc…, isolates of the outbreak of Morel’s disease in Alsamra 
village. 
Ref
1
= ATCC35844/DSM no. 20714, 
Ref
2
= IBT-Göttingen Culture Collection no.9199/2628. 
MW= molecular mass marker: λ DNA-Hind III/ФXHaeIII (Finnzymes, 
Espoo, Finland).  
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MW    k1   k8    k10  k11  k17  k18   k22 k41  G2  G35 G40  G58  -ve 
 Fig. 8: Agarose gel (2%) electrophoresis results of amplification o f kat 
gene of S. aureus subsp. anaerobius isolates using primers 808F and 
1583R. Abbreviations as in Fig. 7. 
 
MW Ref
1
 Ref
2
  G97 S10   k1  -ve  Ref
1
 Ref
2
 G97 S10  k1  -ve  
 
Fig. 9: Agarose gel (2%) electrophoresis results of amplification of kat 
gene of S. aureus subsp. anaerobius isolates using primers 1396F and 
1583R (lanes 2, 3, 4, 5, 6, 7), 164F and 872R (lanes 8, 9, 10, 11, 12, 13). 
Abbreviations as in Fig. 7. 
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a) 
 MW   k1   k8   k10  k11  k17  k18  k22  k41  G2  G35  G40  G42 -ve 
 
b) 
MW  G58 G97  S7   S8    S9   S10  S14  S16  S18 S19 Ref1 Ref2 -ve 
 
Fig. 10 a and b: Agarose gel (2%) electrophoresis results of amplification 
of kat gene of S. aureus subsp. anaerobius isolates using primers 164F 
and 1583R. Abbreviations as in Fig. 7. 
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Table 11: The complete sequence of the catalase-like protein gene of S. 
aureus subsp. anaerobius strain S10 (isolated from outbreak of Morel’s 
disease in Alsamra village, Khartoum North Sudan) 
 
GCTTTTTAAGTGTACTATTCAATAACTATTTAGTACTGTAAAGCGAAAAAA
ATAAAATTTTCTGATTTTTTAATCATCTTGAGCATGTTTAATTGTAATTCTG
ATGGGGTTAAATTATAATATGTATTAAATTATAATTATTATAAATTGTGGA
GGGATGACTATGTCACAACAAGACAAAAAGTTAACTGGTGTTTTTGGGCA
TCCAGTATCAGATCGAGAAAATAGTATGACAGCAGGGCCTAGGGGACCTC
TTTTAATGCAAGATATTTACTTTTTAGAGCAAATGTCTCAATTTGATAGAG
AAGTAATACCAGAACGTCGAATGCATGCCAAAGGTTCTGGTGCATTTGGG
ACATTTACTGTAACTAAAGATATAACAAAATATACGAATGCTAAAATATT
CTCTGAAATAGGTAAGCAAACCGAAATGTTTGCCCGTTTCTCTACTGTAGC
AGGAGAACGTGGTGCTGCTGATGCGGAGAGTGACATTCGAGGATTTGCGT
TAAAGTTCTACACTGAAGAAGGAAACTGGGATTTAGTAGGGAATAACACA
CCAGTATTCTTCTTTAGAGATCCAAAGCTATTTGTTAGTTTAAATCGCGCG
GTGAAACGAGATCCTAGAACAAATATGAGAGATGCACAAAATAACTGGG
ATTTCTGGACGGGGCTTCCAGAAGCATTGCACCAAGTAACGATCTTAATG
TCAGATAGAGGGATTCCTAAAGATTTACGTCACATGCATGGGTTCGGTTC
ACACACATACTCTATGTATAATGATTCTGGTGAACGTGTTTGGGTTAAACT
CCATTTTAGAACGCAACAAGGTATTGAAAACTTAACTGATGAAGAAGCTG
CTGAAATTATAGCAACAGGTCGTGATTCATCTCAACGCGATTTATTCGAAG
CCATTGAAAAAGGTGATTATCCAAAATGGACAATGTATATTCAAGTAATG
ACTGAGGAACAAGCTAAAAACCATAAAGATAATCCATTTGATTTAACAAA
AGTATGGTATCACGATGAGTATCCTCTAATTGAAGTTGGAGAGTTTGAATT
AAATAGAAATCCAGATAATTACTTTATGGATGTTGAACAAGTTGCGTTTGC
ACCAACTAATATTATTCCAGGATTAGATTTTTCTCCAGACAAAATGCTGCA
AGGGCGTTTATTCTCATATGGCGATGCGCAAAGATATTGATTAGGAGTTA
ATCATTGGCAGATTCCTGTAAACCAACCTAAAGGTGTGGGTATTGAAAAT
ATTTGTCCTTTTAGTAGAGATGGTCAAATGCGCGTAGTTGACAATAACCAA
GGTGGAGGAACACATTATTATCCAAATAACCATGGTAAATTTGATTCTCA
ACCTGAATATAAAAAGCCACCATTCCCAACTGATGGATACGGCTATGAAT
ATAATCAACGTCAAGATGATGATAATTATTTTGAACAACCAGGTAAATTG
TTTAGATTACAATCAGAGGGCGCTAAAGAAAGAATTTTTACAAATACAGC
AAATGCAATGGAAGGCGTAACGGATGATGTTAAACGACGTCATATTCGTC
ATTGTTACAAAGCTGACCCAGAATATGGTAAAGGTGTTGCAAAAGCATTA
GGTATTGATATAAATTCTATTGATCTTGAAACTGAAAATGATGAAACATA
CGAAAACTTTGAAAAATAAATTTGATATGTAGTTTCTATATTGCGTAGTTG
AGCAGTTTATGA 
ATG: initiation codon. 
TGA: stop codon 
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                  108 
S10        AGERGAADAESDIRGFALKFYTE 
SA         AGERGAADAERDIRGFALKFYTE  
 
                                 215                                                    238 
S10 MYNDSGERVWVKLHFRTQQGIENLTDEEAAEIIATGRD 
SA MYNDSGERVWVKFHFRTQQGIENLTDEEAAEIIATDRD  
                                                                                                   
                           313               
S10        RNPDNYFMDVEQVAFAPTNII  
SA         RNPDNYFMDVEQAAFAPTNII  
 
                 346 
S10        FSYGDAQRY*LGVNHWQIPVNQPK 
SA         FSYGDAQRYRLGVNHWQIPVNQPK  
 
                        440 
S10       QDDDNYFEQPGKLFRLQSEGAKERIFTNTANA 
SA        QDDDNYFEQPGKLFRLQSEDAKERIFTNTANA 
 
Fig. 11: Illustration of the amino acids substitutions in the catalase 
protein of S. aureus subsp. aureus NCTC 8325 (SA) and the deduced 
catalase- like protein of S. aureus subsp. anaerobius strain S10 (S10). 
The figures indicate the position of the amino acids. 
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Table 12: Nucleotide substitutions in the sequence of the catalase-like 
protein gene of S10 compared with that of S. aureus subsp. anaerobius 
MVF 213 and S. aureus NCTC 8325   
No. Nucletoide 
position  
S10  MVF213 NCTC 8325  
1 52 A  T 
2 61 T G T 
3 101 C  T 
4 217 T  C 
5 485 A  C 
6 529 A  G 
7 584 C  T 
8 604 C  T 
9 670 G  T 
10 739 C  T 
11 757 A  T 
12 806 C  T 
13 871 A  T 
14 876 G  A 
15 1101 T  C 
16 1112 C T C 
17 1199 T C C 
18 1249 G  T 
19 1482 G  A 
20 1501 T Deletion T 
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Table 13: Amino acids resulted from nucleotide mutations in the 
sequence of the catalase like protein gene of S10 compared with that of S. 
aureus subsp. anaerobius MVF 213 and S. aureus NCTC 832  
Nucletoide 
position  
S10 MVF213 NCTC 8325 
485  R (Arginine) 
(AGT) 
 S (Serine) (CGT) 
806  L (Leucine) 
(CTC) 
 F (phenylalanine) 
(TTC) 
876  G (Glycine) 
(GGT) 
 D (Aspartic 
acid)(GAT) 
1101  V (Valine) 
(GTT) 
 A (Alanine) (GCT) 
1112  P(Proline) 
(CCA) 
S (Serine) 
(TCA) 
P (Proline) (CCA) 
1199  STOP CODON 
(TGA) 
R (Arginine) 
(CGA) 
R (Arginine) 
(CGA) 
 
 
3.9.4 RAPD- PCR 
3.9.4.1 Optimization of the reaction mixture 
 The optimum MgCl2 concentration for the RAPD-PCR test was 
found to be 0.75 µl per reaction and it was used for all reactions. 
3.9.4.2 RAPD- PCR amplification pattern 
All local isolates plus one reference strain (ATCC35844/DSM no. 
20714) had identical RAPD patterns with the two primers used, but they 
were different from the other reference strains. Primer 786 yielded two 
clear bands of about 1350 and 700 bp, while primer 798 yielded 5-8 
bands. A clear band was about 500. Other bands were 400, 800, 900, 
1000 and 1350 bp (Fig. 12 and 13). 
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a) 
 MW    k1     k8     k10     k11    k17    k18    k22    k41   G2     G35   G40   G42  G58  Ref2 
 
 
b) 
 MW     G97    S7    S8      S9    S10    S14   S16   S18   S19    Ref1  Ref2 -ve 
 
Fig. 12: Agarose gel (1%) electrophoresis results of amplification 
of RAPD-PCR profiles of Staphylococcus aureus subsp. 
anaerobius strains using primer 786. Abbreviations as in Fig. 7 
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a)   
 MW   k1     k8     k10    k11   k17   k18    k22   k41    G2   G35    G40   G42 G58  Ref2 
 
b)  
MW   S18  S19  G97   S7    S8    S9    S10  S14  S16  Ref1 Ref2 -ve 
 
Fig. 13: Agarose gel (1%) electrophoresis results of RAPD-PCR of 
Staphylococcus aureus subsp. anaerobius isolates using primer 798.  
Abbreviations as in Fig. 7 
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3.9.5 Polymorphism of coa and spa gene markers 
With primers for protein A encoding gene (spa) all local strains in 
addition to one reference strain (DSM no. 20714, ATCC35844) yielded 
amplicons of ~100 bp, while the other reference strain yielded a band of 
~300 bp (Fig. 14).  
With primers the coagulase gene (coa) all local isolates, yielded 
one band of about 550 bp, while one of the two reference strains yielded a 
band of about 600 and the other a band of about 700 bp (Fig. 15). 
3.9.6 Pulsed-field gel electrophoresis (PFGE) 
Pulsed-field gel electrophoresis of genomic DNA from the local 
strains, after digestion with restriction endonuclease SmaI, revealed 
identical restriction pattern, which was distinct for the restriction pattern 
of the reference strain. 
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a) 
MW  k1  k8  k10 k11 k17 k18 k22 k41G2G35 G40 G42 G58 G97 S7 S8 S9S10 MW 
 
b) 
MW  S14  S16  S18   S19  Ref1 Ref2 
 
Fig. 14 a and b: Agarose gel (2%) electrophoresis of PCR products using 
primers for the spa gene for different S. aureus subsp. anaerobius 
isolates. 
 Abbreviations as in Fig. 7. 
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a)   
 MW    k1   k8      k10    k11   k17   k18   k22    k41   G2  G35  G40   Ref
1
 Ref
2
 -ve 
 
B) 
 G42  G58 G97  S7  S8  S9  S10 S14 S16  S18  S19 MW 
 
Fig. 15 a and b: Agarose gel (2%) electrophoresis of PCR products using 
primers for the coa gene for different S. aureus subsp. anaerobius 
isolates. Abbreviations as in Fig. 7.  
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3.4 Pathogenecity of S. aureus subsp. anaerobius and the abscess 
causing dose 
The aim of this experiment was to confirm the ability of S. aureus 
subsp. anaerobius isolates to cause abscess formation in sheep before 
conducting the vaccination and challenge experiments. All tested 
inoculum sizes of S. aureus subsp. anaerobius were able to cause abscess 
formation. The minimum dose used was 480 cfu. Abscess formation at 
the site of inoculation is shown in Fig. 16.  
3.5 Pathogenecity of other staphylococci 
I) All animals inoculated with one species of Staphylococcus showed 
visible swellings at the sites of inoculation followed by abscess formation 
only in animals inoculated with S. aureus subsp. anaerobius and S. 
aureus. The size of the abscess reached up to 6.4x4.5 cm in diameter. 
Animals inoculated with the other species (i.e. S. caseolyticus, S. 
lugdunensis, S. epidermidis and S. simians) showed no abscesses 
formation, neither at the sites of inoculation nor in the superficial lymph 
nodes, but enlargement of some of these lymph nodes. In animals 
inoculated with S. caseolyticus, the right prescapular lymph node showed 
focal areas of caseation. Except those inoculated with S. epidermidis and 
S. lugdunensis, all animals showed infiltration of micro abscesses in the 
liver and abscesses in the lung of the animal inoculated with S. aureus 
subsp. anaerobius (Fig. 17 and 18, respectively). Post-mortem results of 
sheep inoculated with Staphylococcus spp. are shown in the Table 14. 
II) All animals inoculated with mixture of S. aureus anaerobius and one 
of the other staphylococci showed abscesses at the inoculation sites and 
in the prescapular lymph nodes. While S. aureus anaerobius was 
recovered from abscesses of all animals, the other inoculated organism 
was recovered only from those inoculated with S. aureus and S. 
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caseolyticus. 
 
Table 14: Postmortem lesions on non-vaccinated sheep after inoculation 
with some Staphylococcus spp.  
 S. aureus 
subsp. 
anaerobius 
S. 
lugdunensis 
S. 
caseolyticus 
S. aureus S. 
epidermidis 
S. simians 
 
Inoculation 
Site 
Pus, 
swelling 
- - Pus, 
swelling 
- - 
Prescapular 
L.N. 
R/enlarged 
L/Haem. 
R/L 
enlarged 
R/ enlarged, 
caseated. 
L/ enlarged 
- R/ enlarged L/ Haem. 
Parotid L.N. - - - - R/ L 
enlarged 
R/L 
enlarged 
Submandibular 
L.N. 
- - - - - L/ enlarged 
Mesenteric 
L.N. 
-  Corded - - - Enlarged 
and corded 
Precrural - - - R/L Haem. - - 
Popliteal L.N. - - - - - - 
Liver  micro-
abscesses, 
adhesion 
of liver and 
pluera 
- Micro- 
abscesses 
Focal area 
of 
calcification 
- Micro-  
abscesses  
Lung Abscess - - - - - 
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Fig 16: The inoculation site of sheep with different numbers of the 
bacterial cells (CFU) of Staphylococcus aureus subsp. anaerobius. 
 
 
Fig.17: Micro-abscesses in the liver of ram experimentally inoculated 
with Staphylococcus aureus subsp. anaerobius. 
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Fig. 18: Abscess formation in the lung of lamb experimentally inoculated 
with Staphylococcus aureus subsp. anaerobius 
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3.6 Determination of the effective dose of the vaccine 
All vaccinated animals showed visible swellings at the sites of 
injection followed by increase in temperature, which dropped two days 
after challenge. In all vaccinated and challenged animals, except those 
vaccinated with 0.5 ml and boostered with 0.25 ml, some postmortem 
lesions could be observed in superficial lymph nodes, lung or liver (Table 
15). 
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Table 15: Postmortem lesions of sheep inoculated with different doses of 
the vaccine and challenged by 1200 cfu of Staphylococcus aureus subsp. 
anaerobius 
 
Animal 
group 
 
Liver 
 
Lung 
Lymph nodes 
Pre-
scapular  
Mes-
enteric  
Popliteal  
A - Micro 
abscesses 
Haemo-
rrhagic 
Enlarged - 
B - - R/L 
Haemo-
rrhagic 
- R/L 
Haemo-
rrhagic 
C Congestion, 
calcification, 
micro-
abscesses 
- - Cording - 
D - - R/ 
Inflammed 
- - 
E - - - - - 
F Adhesion 
between 
pleura and 
liver, 
calcification,  
necrotic foci 
Abscessat
-ion,  
Adhesion 
Inflamed 
with pus 
Enlarged 
and 
corded 
- 
A:  0.25 ml of vaccine, B:  0.50 ml, C:  0.75 ml, D:  1.00 ml, E:  0.50 ml then 
0.25 ml and F: Control 
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3.7 Challenge 
3.7.1 Challenge using one Staphylococcus species 
All vaccinated sheep that challenged with one species showed 
slight increase in temperature. The temperature increased slightly, and 
dropped two days after challenge. All animals showed neither abscess 
formation at the inoculation sites nor in the internal organs. However, 
animals inoculated with S. aureus subsp. anaerobius and S. aureus 
showed swelling at the sites of inoculation which decreased after 2-3 
days. 
Hematological parameters showed increase in neutrophils and 
slight decrease in PCV in all challenged groups.  
3.7.2 Challenge using two Staphylococcus species  
In animals challenged with two species of Staphylococcus, no 
abscesses formed; neither in superficial lymph nodes nor in internal 
organs.  
Animals challenged with S. aureus subsp. anaerobius + S. aureus 
showed signs of hyper sensitivety reaction: generalized swellings and 
death after one day. At post-mortem, there was froth in the nostrils and 
mouth, subcutaneous oedema (Fig. 24, 25 and 26), congestion in the 
intestines (Figs. 27 and 28), brain (Fig. 29), lung, kidneys and in all 
lymph nodes, froth in the trachea (Fig. 30) hydroprecardium, clots in both 
ventricles (fibrin clot), increased synovial fluid and very flat spleen with 
fibrin clot. 
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Fig. 19: Hyper immune reaction, general swelling in lamb 
vaccinated with Morel’s disease vaccine and challenged by S. 
aureus subsp. anaerobius + S. aureus 
 
 
Fig. 20: Swelling in the chest of lamb vaccinated with Morel’s disease 
vaccine and challenged by S. aureus subsp. anaerobius + S. aureus 
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Fig. 21: Subcutaneous oedema in lamb vaccinated with Morel’s disease 
vaccine and challenged by S. aureus subsp. anaerobius + S. aureus 
 
 
Fig.22: Congestion in the intestine of lamb vaccinated with Morel’s 
disease vaccine and challenged by S. aureus subsp. anaerobius + S. 
aureus 
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Fig. 23: Congestion in the intestine of lamb vaccinated with Morel’s 
disease vaccine and challenged by S. aureus subsp. anaerobius + S. 
aureus 
 
 
Fig. 24: Congestion in the brain of lamb vaccinated with Morel’s disease 
vaccine and challenged by S. aureus subsp. anaerobius + S. aureus 
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Fig. 25: Froth in the trachea of lamb vaccinated with Morel’s disease 
vaccine and challenged by S. aureus subsp. anaerobius + S. aureus  
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3.8 Immunological tests 
3.8.1 Effect of vaccination with Morel’s disease vaccine on the plaque 
forming cell (PFCs) count 
Plaques (Fig. 31) formed were counted as measure of the level of 
immunity conferred by immunization of sheep with Morel’s disease 
vaccine. Significant increase (p<0.05) in the average number of plaques 
formed occurred one and two weeks after vaccination and a significantly 
higher (p<0.01) number of plaques formed one week after the booster 
dose (Fig. 32).  
3.8.2 Effect of vaccination with Morel’s disease vaccine on the splenic 
lymphocyte count  
Splenic lymphocytes count showed slight increase (p>0.05) one 
week after vaccination, and it increased significantly (p<0.05) two weeks 
after vaccination. Booster dose of the vaccine resulted in very high 
increase of lymphocyte count (Fig. 3). Plaques formed were positively 
correlated with the lymphocytes count. 
3.8.3 Validity of splenic cells  
The purpose of this experiment was to determine for how long the 
splenic cells can remain viable before conducting the PFC assay. The 
splenic cells were stored normally and in two different solutions: RPMI 
and Histopaque at 4°C.  Results are shown in Figs 35-38. While splenic 
cells taken from animals one week after vaccination could not remain 
viable more than one day, they remained viable more than 19 days when 
taken from animals 4 weeks after vaccination. Viability of cells was 
better without storage solution one week after vaccination, but it was best 
when stored in RPMI two weeks after vaccination. While viability was 
almost equal in RPMI and histopaque three weeks, it increased in 
Histopaque four weeks after vaccination. 
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Fig. 26: Photomicrograph of typical Plaque Forming Cell. Note the single 
mononuclear (plasma) cell in the centre of the plaque: the erythrocytes 
were lysed producing holes (clear areas), 40x.  
 
 
 
Fig. 27: Average count of plaques formed of groups of sheep vaccinated 
with Morel’s disease vaccine 
 
 
 
b 
a 
c 
d 
* Values with different letters are significantly different 
(p>0.05) 
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Fig. 28: Average blood lymphocytes count of groups of sheep 
vaccinated with Morel’s disease vaccine 
 
 
Fig. 29: Plaque forming cell assay (PFCA) and lymphocytes count, 
comparison between all groups 
 
a a 
b 
c 
* Values with different letters are significantly different 
(p>0.05) 
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Fig. 30 Viability of splenic cells when stored normally, in RPMI or 
in Histopaque at 4 °C one week after vaccination  
 
Fig. 31: Viability of splenic cells when stored normally, in RPMI 
or in Histopaque at 4 °C two weeks after vaccination  
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Fig. 32: Viability of splenic cells when stored normally, in RPMI 
or in Histopaque at 4 °C three weeks after vaccination 
 
 
Fig. 33: Viability of splenic cells when stored normally, in RPMI 
or in Histopaque at 4 °C four weeks after vaccination 
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3.8.3. Opsonophagocytosis 
This experiment was conducted to evaluate the ability of 
hyperimmune serum against S. aureus subsp. anaerobius to prevent 
abscess formation and to opsonize bacteria to help phagocytosis by 
PMNs. Subsutaneously inoculated bacteria two hours after opsonization 
produced the smallest abscess size compared with that produced by 
imoculation immediately after opsonization and by the control (original 
culture) as seen in Table 16.  
Phagocytosis of opsonized bacteria by PMNs was assessed by the 
bacterial count. Bacterial count of that opsonized by serum taken two 
weeks after vaccination was lower compared with that opsonized with 
serum taken one week after vaccination (Tables 17 and 18). The viable 
count of both S. aureus and S. aureus subsp. anaerobius decreased after 
opsonization, the last count was obtained when opsonized for 2 h. 
   
Table 16: Abscess size produced by inoculation of opsonized culture of 
S. aureus subsp. anaerobius  
Bacterial inoculum Abscess size (cm) 
Original culture (control) 3.92x3.75 
Opsonized for 0 min 2.40x2.50 
Opsonized for 2 hours 1.54x1.63 
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Table 17: Average number of bacteria (per ml) after phagocytosis one 
weeks after vaccination  
Opsonization time 
(min) S. aureus subsp. anaerobius S. aureus 
Control Uncountable Uncountable 
0  Uncountable Uncountable 
 30  Uncountable Uncountable 
60  4.02 x10
4
 6.08 x10
4
 
120 9.85 x10
3
 3.34 x10
4
 
 
Table 18: Average number of bacteria (per ml) after phagocytosis two 
weeks after vaccination 
Opsonization time 
(min) S. aureus subsp. anaerobius S. aureus 
Control Uncountable Uncountable 
0  Uncountable Uncountable 
30  2.35x10
3
 1.1 x10
3
 
60 1.8 x10
3
 8.5 x10
2
 
120 9.5 x10
2
 3.5 x10
2
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CHAPTER FOUR 
DISCUSSION 
In the survey conducted in this study, Staphylococcus spp. were 
isolated in pure cultures from 68.8% of lymph nodes abscesses of sheep 
at meat inspection, Corynebacterium spp. from 26.5% and mixture of 
both organisms were isolated from the rest (4.7%) samples. These results 
suggest that staphylococci are the most prevalnt organisms that can be 
isolated from lymph node abscesses at meat inspection. These results are 
in general agreement with those obtained by Noura Karamalla (1997) and 
Sara Bihary (2002). Noura Karamalla (1997) isolated Staphylococcus 
spp. from 96% of the samples of lymph node abscesses of sheep at meat 
inspection in Alkadaro abattoir, while the rest 4% yielded mixed cultures. 
Sara Bihary (2002) isolated 48.7% Staphylococcus spp., 38.7% 
Corynebacterium spp. and 12.6% mixed culture of both Staphylococcus 
spp. and Corynebacterium spp. from lymph node abscesses of sheep at 
meat inspection in Omdurman abattoir. Among staphylococci isolated in 
this study, S. aureus subsp. anaerobius was the most prevalent (63.2%). 
This percentage of isolation is higher than those of Noura Karamalla 
(1997) and Sara Bihary (2002), 26% and 24%, repectively. Other 
staphylococci isolated were S. caseolyticus (21.3%), S. aureus (11.9%) 
and S. simians, S. lugdunensis, S. warneri, S. epidermidis (each 0.9%). 
Other than S. aureus anaeroboius, only two species viz: S. caseolyticus 
and S. aureus were among the isolates of both Noura Karamalla (1997) 
and Sara Bihary (2002); S. simians and S. lugdunensis were among the 
isolates of Sara Bihary (2002).  
In outbreak of abscess disease at Alsamra village, Khartoum State, 
with morbidity rate of 30%, S. aureus subsp. anaerobius was isolated 
from 28 out of 30 (93.3%) affected sheep, while Corynebacterium spp. 
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was isolated from the rest two (6.7%) animals. These results agree with 
the results of previous investigators on abscess disease of sheep in the 
Sudan (Hamad et al., 1992) and earlier reports of Morel (1911), Ayuand 
(1923) in France in addition to a recent report made by Møller etal. 
(2000) in Denmark, who described S. aureus subsp. anaerobius as the 
cause of abscess disease of sheep. These results show that Staphylococcus 
aureus subsp. anaerobius is the most probable bacterium that can be 
isolated from superficial lymph node abscesses of sheep at meat 
inspection and the most likely cause of abscess disease of sheep in 
pasture. 
Nuc gene encodes for the thermonuclease (TNase) enzyme 
produced by Staphylococcus aureus strains. This gene (nuc) has species 
specific sequence as was indicated by polyclonal and monoclonal 
antibodies to detect S. aureus TNase in addition to DNA hybridization 
test (Liebl et al., 1987). A primer set for the detection of the gene 
encoding this enzyme was designed by Brakstad et al. (1992), which 
generates a PCR product of approximately 270 bp. This primer set was 
used in this study in a PCR test to confirm biochemical identification of 
22 representative local isolates of S. aureus subsp. anaerobius. All tested 
isolates were positive for this gene. 
 On PCR amplification of staphylococcal catalase gene (kat) using 
several primers, these local isolates also gave positive results. But, this 
confirmed the identification of these isolates to the species level only, not 
the subspecies level, i.e., they are S. aureus. Staphylococcus aureus 
subsp. anaerobius differs from S. aureus subsp. aureus in that it is 
catalase and benzidine negative. So, genes coding for one of these two 
proteins should be targeted for differentiation between the two 
subspecies. Catalase gene of S. aureus subsp. anaerobius (katB) was 
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found by Sanz et al. (2000) to have sequence differences from the 
prototype gene (katA) of S. aureus subsp. aureus. So, to confirm the 
identification of the local isolates, the complete catalase gene of one 
outbreak strain (S10) isolated in this study was sequenced.  
Sequence of the putative catalase gene of S. aureus subsp. 
anaerobius strain S10 (SaanS10) showed 99% identity to katB gene of S. 
aureus subsp. anaerobius MVF213 (GenBank accession no. AJ000471), 
katA gene of S. aureus subsp. aureus strains NCTC 8325 and Newman 
(GenBank accession nos.CP000253 and AP00935.1, respectively). In 
comparison with katA, 15 bases substitutions occurred within the coding 
region of katA, six of which were mis-sense mutations while the others 
were silent mutations. An important substitution occurred at position no. 
1099 (1036 bases upstream the initiation codon) of katS10 gene. In 
katS10 the base is “T”, while in katA and katB it is “C”. This substitution 
resulted in the code "TGA" instead of "CGA". This stop codon formula 
for termination of translation rendered the predicted protein to be only 
345 amino acids in length. In S. aureus subsp. aureus (NCTC 8325 and 
Newman strains) the protein of katA is 505 a.a. long. Sanz et al. (2000) 
found that in S. aureus subsp. anaerobius strain MVF213, which is 
catalase negative, the catalase-like protein of katB is 445 a.a. long. Loss 
of the catalase activity of S. aureus subsp. anaerobius is attributed to 
deletion of one base 1338 nucleotides upstream the initiation codon, 
which resulted in shift in the reading frame and premature termination of 
translation 30 bases later (Sanz et al., 2000). In katS10 this deletion did 
not occur, a feature of similarity to katA. The third mismatching of katS10 
and katB is that the substitution which occurred at base 949 upstream the 
initiation codon leading to serine in katB instead of proline in katA (Sanz 
et al., 2000), did not happen in katS10. Interestingly, all mutations 
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occurred in katA gene leading to the generation of katB, except the above 
mentioned ones, also occurred in katS10. This suggests that katA 
underwent mutations in at least two steps leading to the generation of 
katB and katS10.  
To see if these mutations of katS10 are unique features of the local 
strain (S10) or common to all local isolates of S. aureus subsp. 
anaerobius, partial sequence (about 990 bp) of the catalase gene of other 
eight local isolates in addition to one reference strain was performed. The 
segment of the gene chosen for this partial sequence targeted a region that 
contained most of the mutations seen in katS10 including position 1099 
of the gene. The sequence of the catalase gene of all of the Sudanese 
isolates was 100% identical to that of katS10 gene, while that of the 
reference strain was 100% identical to katB sequence. These results 
suggest that the mutations of katS10 may be widely present in Sudanese 
strains of S. aureus subsp. anaerobius, and that the strains tested could 
have a common origin. To confirm this assumption, further molecular 
characterization of the local isolates was performed. Twenty two local 
isolates in addition to two reference strains were analysed by RAPD-PCR 
and PCR amplification of two genetic markers: spa (staphylococcal 
protein A) and coa (colagulase) genes. With primers used for RAPD-PCR 
and spa gene all local strains in addition to one of the refrence strains was 
identical in the amplification pattern. But, with primers for the coa gene 
all local isolates gave similar amplification patterns, which were distinct 
from at least one of the reference strains. Furthermore, DNA restriction 
patterns in pulsed field gel electrophoresis (PFGE) of 6 local isolates and 
one reference strain yielded the same results. These results in conjunction 
with the catalase gene sequence results suggest that all Sudanese S. 
aureus subsp. anaerobius isolates originated from one clone. These 
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results are in agreement with the results obtained by El Haj and El 
Sanousi (2005) who reported that the local strains had similar PFGE 
restriction patterns and they were genetically identical. 
Subcutaneous injection of non vaccinated sheep with a dose of 
1.2x10
3 
cfu of S. aureus subsp. anaerobius formed abscesses reached up 
to 6.4x4.5 cm in size; the size measured by Hassan (1996) reached up to 
6.5x6.0 cm while Sara Bihary (2002) found that the size of the formed 
abscesses reached 9.9x9.4 cm. This variation can be due to the 
differences in the inoculums sizes. However, the sizes obtained in these 
experimental infections was smaller from some natural cases: Møller 
(2000) found that it reached 15 cm in diameter, Aynaud (1927) described 
the size of the abscess as a size of two-hand fist, Alhendi et al. (1993) 
described it as a size of a football.   
Ability to form abscesses by other staphylococci isolated in this 
study was also tested. Sheep inoculated with S. aureus formed pus 
discharging abscessses at the inoculation sites, haemorrhage in the left 
and right precrural lymph nodes. In the experiment of Sara Bihary (2002), 
inoculation of S. aureus resulted in small size subcuaneous abscess and 
haemorrhagic precrural lymph node. Animals inoculated with the other 
species (S. caseolyticus, S. lugdunensis and S. simians) showed no 
abscesses formation at the sites of inoculation. Sara Bihary (2002) 
described different sizes of abscesses formed at the sites of inoculation 
when she used these species for experimental infection. S. caseolyticus 
produced caseated abscess at the prescapular lymph node. Sara Bihary 
(2002) described abscess formation in the prescapular lymph node. 
Haemorrhage, enlargement of the submandibular, parotid and mesenteric 
lymph nodes were seen in the sheep inoculated with S. simians. Sara 
Bihary (2000) found only haemorrhagic prescapular lymph node in 
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animals inoculated with S. simians. Animals inoculated with S. 
lugdunensis showed enlargement and cording of the mesenteric lymph 
nodes. Sara Bihary (2002) found haemorrhagic prescapular lymph node 
and abscesses in the liver. Sheep inoculated with S. epidermidis showed 
enlargement of the prescapular and parotid lymph nodes. However, 
infiltration with micro abscesses was seen in the livers of animals 
inoculated with S. caseolyticus and S. simians. Failure of staphylococci 
(other than S. aureus and S. aureus subsp. anaerobius) to produce 
subcuataneous abscesses in sheep in this study suggests that they can not 
cause clinical abscess disease, but only inflammation of lymph nodes or 
micro abcesses in some internal organs that can be detected at meat 
inspection. Thes results contradict the results of Sara Bihary (2002), who 
showed abscesses formation in sheep inoculated with 10 different 
Staphylococcus spp. (other than S. aureus and S. aureus anaerobius) 
including three species isolated in this study. This may be due to the 
difference of inoculum sizes used in the two experiments: while the 
inoculum size used in this study was 1200 cfu (three times the minimum 
in vitro abscess causing dose of S. aureus anaerobius), Sara Bihary used 
inoculum size equal to Brown’s opacity tube no. 4 (equivalent to about 
10
9
 cfu), which means one million times the minimum abscess causing 
dose. 
Experimental inoculations of S. aureus anaerobius plus one of the 
other staphylocci isolated in this study was conducted on the assumption 
that there is synergistic action between S. aureus anaerobius and these 
staphylococci. This assumption was made because some of these 
staphylococci were isolated form abscess in mixtures with S. aureus 
anaerobius. Except in the cases of S. aureus and S. caseolyticus, none of 
the other staphylococci could be recovered from the abscesses developed 
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(at the inoculation sites and prescapular prescapular lymph nodes). 
Results of this experiment can augment this assumption of synergism to 
cause clinical abscess disease only to some extent and for only these two 
organisms.  S. aureus was able to cause clinical abscess disease, and S. 
caseolyticus formed only lymph node abscess when inoculated alone.  
In the present investigation, the effective dose of Morel’s disease 
vaccine was evaluated. A dose of 0.5 ml of the vaccine boostered with 
0.25 ml after fifteen days gave protection against challenge with three 
times the minmum abscess causing dose, as indicated by prevention of 
development of any lesion. Also, 1 ml of the vaccine gave protection, but 
prescapular lymph node was enlarged. With doses of 0.25, 0.50 and 0.75, 
prevention of abscess formation could occur, but inflammation of many 
lymph nodes had also occured. Rodwan (1996) reported that the effective 
dose of the vaccine was 1 ml boostered with 0.5 ml after fifteen days. 
These results proved the possibility of minimizing the dose to the half and 
giving the same protection. The positive economic impact on production 
of the vaccine of these results is that the same production size can be used 
for the double number of animals without additional costs.  
When vaccinated sheep were challenged with a mixture of both S. 
aureus anaerobius and S. aureus, signs indicative of hyper immune 
reaction were seen (generalized oedema of both challenged animals and 
death of one animal). The protein content of Morel’s disease vaccine is 
high (Hassan, 2000) and it is expected that it provokes both humoral and 
cell mediated immunity against a large number proteomes comprising its 
protein in vaccinated animals. Since S. aureus anaerobius and S. aureus 
belong to one species, it is expected that lots of antigens are shared 
against which immune response is elicited in animlas vaccinated with 
Morel’s disease vaccine. The delayed type of hypersensitivity reaction 
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occurred in challenged lambs is thus can be attributed to the very big 
number of organisms used in the challenge (2,400,000 cfu), and of course 
the high protein concentration thereof. This reaction can not be expected 
to happen in nature in vaccinated animals because naturally occurring 
infections are caused by a very small number of organisms. 
The plaque-forming cell (PCF) assay is an in vitro enumeration of 
antibody (mainly IgM) secreting cells. Hassan (2000) used this assay to 
compare between immune responses against S. aureus anaerobius in 
sheep vaccinated with Morel’s disease vaccine and non vaccinated sheep. 
He found that the percetage of PFCs ranged from 75-81.59% and 0.42-
2.0% for the vaccinated and non-vaccinated lambs, respectively. Hassan 
(2000) found this assay to be the best choice to study immunity against S. 
aureus anaerobius. So, the PFC assay was used in this study to monitor 
immunity against S. aureus anaerobius in sheep vaccinated with Morel’s 
disease vaccine. Results of this study in PFC assay were in agreement 
with the findings of Hassan (2000). Furthermore, although significant 
increase in the number of plaques formed by spelnic cells of all groups of 
vaccinated sheep was seen, the number of plaques was the highest in the 
group given a booster dose. This result accords with the challenge 
experiment results, in which animals given a booster dose of the vaccine 
were more protected. Splenic lymphocytes also increased significantly 
two weeks after vaccination and the highest increase was seen one week 
after the booster dose. The positive correlation between the splenic 
lymphocyte and plaque forming cells counts indicates proliferation of 
cells secreting antibodies against S. aureus anaerobius, which conferred 
immunity against Morel’s disease.  
In practical, PFC has many limitations, one of which is the time 
elapse before conducting the assay after taking the spleens from animals. 
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To see if this assay can be conducted in another day of taking the spleens 
from animals, viablitiy of spleenic cells was tested when stored in two 
different solutions; RPMI and Histopaque at 4 °C and compared with the 
original buffer. Although there were differences in the ability of the 
solutions to keep the spelnic cells alive, and there were also differences in 
vibilty of splenic cells taken at different times after vaccination, but it can 
generally be concluded that it is better not to use storage solution for the 
splenic cells and to conduct the assay in the same day of taking spleens 
when dealing with animals one week after vaccination; to use RPMI as 
storage solution when dealing with animals two or three weeks after 
vaccination; to use Histo as storage solution when dealing with animals 
three or four weeks after vaccination, and to conduct the assay in the 
second day in when using either RPMI and Histopaqe. 
Another measure of immunity against S. aureus anaerobius in 
sheep vaccinated with Morel’s disease vaccine used in this study was the 
opsonizating ability of the hyperimmune sera to promote phagocytosis 
and/or killing by the complement. This was assessed by two indicatiors: 
viable count of bacteria after opsonization and ability of opsonized 
bacteria to cause abscess formation in experimental infection. The 
abscess size caused by inoculation of opsonized bacteria was smaller than 
that caused by the non-opsonized. Also, the bacterial count decreased 
sharply after opsonization, which positvely correlated with the time of 
opsoniztion. Furthermore, immune serum taken two weeks after 
vaccination gave better opsonization than serum taken one week after 
vaccination. These results are in agreement with Hassan (2000) who 
found significant increase in opsonizating antibodies in sera of vaccinated 
lambs.  
However, both PFC assay and opsonophagocytosis experiments 
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were indicative of increased antibodies against different antigenic 
components of Morel’s disease vaccine in sera of vaccinated animals. 
While this is so, a better method for detection of immunity of 
vaccinated sheep against virulant staphylococci warrants future 
investigation. 
Conclusions and recommendations 
 S. aureus subsp. anaerobius is the major cause of clinical abscess 
disease of sheep. 
 Other staphylococci can cause superficial lymph node abscesses 
that can be detected at meat inspection (subclinical abscess 
disease), but they are likley not able to cause the classical clinical 
subcutaneous abscess syndrome of Morel’s disease. 
 All Sudanese strains of S. aureus subsp. anaerobius seem to have 
originated from one clone and thus any one of the local stains can 
be used for vaccine production. 
 The minimum protecting dose of Morel’s disease vaccine is 0.5 ml 
boostered with 0.25 ml after fifteen days. Also, a single dose of 1 
ml of the vaccine is effective. 
 Vaccination of sheep with Morel’s disease vaccine increases the 
concentration of antibodies raised against both S. aureus 
anaerobius and S. aureus. 
 Although the plaque forming cell assay served as a good 
immunological test to monitor immunity conferred by vaccination 
with Morel’s disease vaccine by enumerating antibody secreting 
cells against S. aureus subsp. anaerobius, it can not be performed 
effectively in live animals. 
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 Findig reliable immunological test(s) for the assessment of 
immunity level of live animals remains a challenge of future 
studies.  
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APPENDIX 
 
Appendix 1: The complete sequence of the catalase gene of strain (S10) 
deposited in the GenBank, accession no EU 281993 
  
 
My NCBI  
[Sign In]  [Register] 
PubMed  Nucleotide  Protein  Genome  Structure  PMC  Taxonomy  OMIM  Books  
 
 Search 
Nuc leotide
  for   
Go
   
 
1:  EU281993. Reports  Staphylococcus au...[gi:161406804]  Links 
 Features  
 Sequence 
LOCUS       EU281993                1725 bp    DNA     linear   BCT 
05-DEC-2007 
DEFINITION  Staphylococcus aureus subsp. anaerobius strain S10 
catalase-like 
            protein gene, complete cds. 
ACCESSION   EU281993 
VERSION     EU281993.1  GI:161406804 
KEYWORDS    . 
SOURCE      Staphylococcus aureus subsp. anaerobius 
  ORGANISM  Staphylococcus aureus subsp. anaerobius 
            Bacteria; Firmicutes; Bacillales; Staphylococcus. 
REFERENCE   1  (bases 1 to 1725) 
  AUTHORS   Musa,N.O., Eltom,K., Babiker,A., El Sanousi,S.M., 
Gessler,F. and 
            Boehnel,H. 
  TITLE     Analysis of the catalase gene of a Sudanese strain of 
            Staphylococcus aureus subsp. anaerobius 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 1725) 
  AUTHORS   Musa,N.O., Eltom,K., Babiker,A., El Sanousi,S.M., 
Gessler,F. and 
            Boehnel,H. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (14-NOV-2007) Tropical Animal Health, 
            Georg-August-University of Goettingen, Kellnerweg 6, 
Goettingen 
            37077, Germany 
FEATURES             Location/Qualifiers 
     source          1..1725 
                     /organism="Staphylococcus aureus subsp. 
anaerobius" 
                     /mol_type="genomic DNA" 
                     /strain="S10" 
                     /sub_species="anaerobius" 
                     /db_xref="taxon:72759" 
                     /country="Sudan" 
     CDS             164..1201 
                     /codon_start=1 
                     /transl_table=11 
                     /product="catalase-like protein" 
                     /protein_id="ABX71760.1" 
                     /db_xref="GI:161406805" 
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/translation="MSQQDKKLTGVFGHPVSDRENSMTAGPRGPLLMQDIYFLEQMSQ 
FDREVIPERRMHAKGSGAFGTFTVTKDITKYTNAKIFSEIGKQTEMFARFSTVAGERG 
AADAESDIRGFALKFYTEEGNWDLVGNNTPVFFFRDPKLFVSLNRAVKRDPRTNMRDA 
QNNWDFWTGLPEALHQVTILMSDRGIPKDLRHMHGFGSHTYSMYNDSGERVWVKLHFR 
TQQGIENLTDEEAAEIIATGRDSSQRDLFEAIEKGDYPKWTMYIQVMTEEQAKNHKDN 
PFDLTKVWYHDEYPLIEVGEFELNRNPDNYFMDVEQVAFAPTNIIPGLDFSPDKMLQG 
RLFSYGDAQRY" 
 
ORIGIN       
  1 gctttttaag tgtactattc aataactatt tagtactgta aagcgaaaaa aataaaattt 
 61 tctgattttt taatcatctt gagcatgttt aattgtaatt ctgatggggt taaattataa 
121 tatgtattaa attataatta ttataaattg tggagggatg actatgtcac aacaagacaa 
181 aaagttaact ggtgtttttg ggcatccagt atcagatcga gaaaatagta tgacagcagg 
241 gcctagggga cctcttttaa tgcaagatat ttacttttta gagcaaatgt ctcaatttga 
301 tagagaagta ataccagaac gtcgaatgca tgccaaaggt tctggtgcat ttgggacatt 
361 tactgtaact aaagatataa caaaatatac gaatgctaaa atattctctg aaataggtaa 
421 gcaaaccgaa atgtttgccc gtttctctac tgtagcagga gaacgtggtg ctgctgatgc 
481 ggagagtgac attcgaggat ttgcgttaaa gttctacact gaagaaggaa actgggattt 
541 agtagggaat aacacaccag tattcttctt tagagatcca aagctatttg ttagtttaaa 
601 tcgcgcggtg aaacgagatc ctagaacaaa tatgagagat gcacaaaata actgggattt 
661 ctggacgggg cttccagaag cattgcacca agtaacgatc ttaatgtcag atagagggat 
721 tcctaaagat ttacgtcaca tgcatgggtt cggttcacac acatactcta tgtataatga 
781 ttctggtgaa cgtgtttggg ttaaactcca ttttagaacg caacaaggta ttgaaaactt 
841 aactgatgaa gaagctgctg aaattatagc aacaggtcgt gattcatctc aacgcgattt 
901 attcgaagcc attgaaaaag gtgattatcc aaaatggaca atgtatattc aagtaatgac 
961 tgaggaacaa gctaaaaacc ataaagataa tccatttgat ttaacaaaag tatggtatca 
1021cgatgagtat cctctaattg aagttggaga gtttgaatta aatagaaatc cagataatta 
1081ctttatggat gttgaacaag ttgcgtttgc accaactaat attattccag gattagattt 
1141ttctccagac aaaatgctgc aagggcgttt attctcatat ggcgatgcgc aaagatattg 
1201attaggagtt aatcattggc agattcctgt aaaccaacct aaaggtgtgg gtattgaaaa 
1261tatttgtcct tttagtagag atggtcaaat gcgcgtagtt gacaataacc aaggtggagg 
1321aacacattat tatccaaata accatggtaa atttgattct caacctgaat ataaaaagcc 
1381accattccca actgatggat acggctatga atataatcaa cgtcaagatg atgataatta 
1441ttttgaacaa ccaggtaaat tgtttagatt acaatcagag ggcgctaaag aaagaatttt 
1501tacaaataca gcaaatgcaa tggaaggcgt aacggatgat gttaaacgac gtcatattcg 
1561tcattgttac aaagctgacc cagaatatgg taaaggtgtt gcaaaagcat taggtattga 
1621tataaattct attgatcttg aaactgaaaa tgatgaaaca tacgaaaact ttgaaaaata 
1681 aatttgatat gtagtttcta tattgcgtag ttgagcagtt tatga 
// 
Disclaimer | Write to the Help Desk 
NCBI | NLM | NIH 
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Appendix 2: Catalase gene of strain S10 (Sudanese strain) in comparison 
with the gene of the catalase-like protein of Staphylococcus aureus subsp. 
anaerobius strain MVF 213 
emb|AJ000471.1|SAMVFCATA  Staphylococcus aureus catalase gene, strain 
MVF213 
Length=1758  
Score = 3162 bits (1712), Expect = 0.0 
Identities = 1721/1725 (99%), Gaps = 1/1725 (0%) 
Strand=Plus/Plus 
 
Query  1     GCTTTTTAAGTGTACTATTCAATAACTATTTAGTACTGTAAAGCGaaaaaaaTAAAATTT  60 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  3     GCTTTTTAAGTGTACTATTCAATAACTATTTAGTACTGTAAAGCGAAAAAAATAAAATTT  62 
 
Query  61    TCTGATTTTTTAATCATCTTGAGCATGTttaattgtaattctgatggggttaaattataa  120 
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  63    GCTGATTTTTTAATCATCTTGAGCATGTTTAATTGTAATTCTGATGGGGTTAAATTATAA  122 
 
Query  121   tatgtattaaattataattattataaattGTGGAGGGATGACTATGTCACAACAAGACAA  180 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  123   TATGTATTAAATTATAATTATTATAAATTGTGGAGGGATGACTATGTCACAACAAGACAA  182 
 
Query  181   AAAGTTAACTGGTGTTTTTGGGCATCCAGTATCAGATCGAGAAAATAGTATGACAGCAGG  240 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  183   AAAGTTAACTGGTGTTTTTGGGCATCCAGTATCAGATCGAGAAAATAGTATGACAGCAGG  242 
 
Query  241   GCCTAGGGGACCTCTTTTAATGCAAGATATTTACTTTTTAGAGCAAATGTCTCAATTTGA  300 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  243   GCCTAGGGGACCTCTTTTAATGCAAGATATTTACTTTTTAGAGCAAATGTCTCAATTTGA  302 
 
Query  301   TAGAGAAGTAATACCAGAACGTCGAATGCATGCCAAAGGTTCTGGTGCATTTGGGACATT  360 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  303   TAGAGAAGTAATACCAGAACGTCGAATGCATGCCAAAGGTTCTGGTGCATTTGGGACATT  362 
 
Query  361   TACTGTAACTAAAGATATAACAAAATATACGAATGCTAAAATATTCTCTGAAATAGGTAA  420 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  363   TACTGTAACTAAAGATATAACAAAATATACGAATGCTAAAATATTCTCTGAAATAGGTAA  422 
 
Query  421   GCAAACCGAAATGTTTGCCCGTTTCTCTACTGTAGCAGGAGAACGTGGTGCTGCTGATGC  480 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  423   GCAAACCGAAATGTTTGCCCGTTTCTCTACTGTAGCAGGAGAACGTGGTGCTGCTGATGC  482 
 
Query  481   GGAGAGTGACATTCGAGGATTTGCGTTAAAGTTCTACACTGAAGAAGGAAACTGGGATTT  540 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  483   GGAGAGTGACATTCGAGGATTTGCGTTAAAGTTCTACACTGAAGAAGGAAACTGGGATTT  542 
 
Query  541   AGTAGGGAATAACACACCAGTATTCTTCTTTAGAGATCCAAAGCTATTTGTTAGTTTAAA  600 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  543   AGTAGGGAATAACACACCAGTATTCTTCTTTAGAGATCCAAAGCTATTTGTTAGTTTAAA  602 
 
Query  601   TCGCGCGGTGAAACGAGATCCTAGAACAAATATGAGAGATGCACAAAATAACTGGGATTT  660 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  603   TCGCGCGGTGAAACGAGATCCTAGAACAAATATGAGAGATGCACAAAATAACTGGGATTT  662 
 
Query  661   CTGGACGGGGCTTCCAGAAGCATTGCACCAAGTAACGATCTTAATGTCAGATAGAGGGAT  720 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  663   CTGGACGGGGCTTCCAGAAGCATTGCACCAAGTAACGATCTTAATGTCAGATAGAGGGAT  722 
 
Query  721   TCCTAAAGATTTACGTCACATGCATGGGTTCGGTTCACACACATACTCTATGTATAATGA  780 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  723   TCCTAAAGATTTACGTCACATGCATGGGTTCGGTTCACACACATACTCTATGTATAATGA  782 
 
Query  781   TTCTGGTGAACGTGTTTGGGTTAAACTCCATTTTAGAACGCAACAAGGTATTGAAAACTT  840 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  783   TTCTGGTGAACGTGTTTGGGTTAAACTCCATTTTAGAACGCAACAAGGTATTGAAAACTT  842 
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Query  841   AACTGATGAAGAAGCTGCTGAAATTATAGCAACAGGTCGTGATTCATCTCAACGCGATTT  900 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  843   AACTGATGAAGAAGCTGCTGAAATTATAGCAACAGGTCGTGATTCATCTCAACGCGATTT  902 
 
Query  901   ATTCGAAGCCATTGAAAAAGGTGATTATCCAAAATGGACAATGTATATTCAAGTAATGAC  960 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  903   ATTCGAAGCCATTGAAAAAGGTGATTATCCAAAATGGACAATGTATATTCAAGTAATGAC  962 
 
Query  961   TGAGGAACAAGCTAAAAACCATAAAGATAATCCATTTGATTTAACAAAAGTATGGTATCA  1020 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  963   TGAGGAACAAGCTAAAAACCATAAAGATAATCCATTTGATTTAACAAAAGTATGGTATCA  1022 
 
Query  1021  CGATGAGTATCCTCTAATTGAAGTTGGAGAGTTTGAATTAAATAGAAATCCAGATAATTA  1080 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1023  CGATGAGTATCCTCTAATTGAAGTTGGAGAGTTTGAATTAAATAGAAATCCAGATAATTA  1082 
 
Query  1081  CTTTATGGATGTTGAACAAGTTGCGTTTGCACCAACTAATATTATTCCAGGATTAGATTT  1140 
             ||||||||||||||||||||||||||||||| |||||||||||||||||||||||||||| 
Sbjct  1083  CTTTATGGATGTTGAACAAGTTGCGTTTGCATCAACTAATATTATTCCAGGATTAGATTT  1142 
 
Query  1141  TTCTCCAGACAAAATGCTGCAAGGGCGTTTATTCTCATATGGCGATGCGCAAAGATATTG  1200 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||| | 
Sbjct  1143  TTCTCCAGACAAAATGCTGCAAGGGCGTTTATTCTCATATGGCGATGCGCAAAGATATCG  1202 
 
Query  1201  ATTAGGAGTTAATCATTGGCAGATTCCTGTAAACCAACCTAAAGGTGTGGGTATTGAAAA  1260 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1203  ATTAGGAGTTAATCATTGGCAGATTCCTGTAAACCAACCTAAAGGTGTGGGTATTGAAAA  1262 
 
Query  1261  TATTTGTCCTTTTAGTAGAGATGGTCAAATGCGCGTAGTTGACAATAACCAAGGTGGAGG  1320 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1263  TATTTGTCCTTTTAGTAGAGATGGTCAAATGCGCGTAGTTGACAATAACCAAGGTGGAGG  1322 
 
Query  1321  AACACATTATTATCCAAATAACCATGGTAAATTTGATTCTCAACCTGAATATAAAAAGCC  1380 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1323  AACACATTATTATCCAAATAACCATGGTAAATTTGATTCTCAACCTGAATATAAAAAGCC  1382 
 
Query  1381  ACCATTCCCAACTGATGGATACGGCTATGAATATAATCAACGTCAAGATGATGATAATTA  1440 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1383  ACCATTCCCAACTGATGGATACGGCTATGAATATAATCAACGTCAAGATGATGATAATTA  1442 
 
Query  1441  TTTTGAACAACCAGGTAAATTGTTTAGATTACAATCAGAGGGCGCTAAAGAAAGAATTTT  1500 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1443  TTTTGAACAACCAGGTAAATTGTTTAGATTACAATCAGAGGGCGCTAAAGAAAGAATTTT  1502 
 
Query  1501  TACAAATACAGCAAATGCAATGGAAGGCGTAACGGATGATGTTAAACGACGTCATATTCG  1560 
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1503  -ACAAATACAGCAAATGCAATGGAAGGCGTAACGGATGATGTTAAACGACGTCATATTCG  1561 
 
Query  1561  TCATTGTTACAAAGCTGACCCAGAATATGGTAAAGGTGTTGCAAAAGCATTAGGTATTGA  1620 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1562  TCATTGTTACAAAGCTGACCCAGAATATGGTAAAGGTGTTGCAAAAGCATTAGGTATTGA  1621 
 
Query  1621  TATAAATTCTATTGATCTTGAAACTGAAAATGATGAAACATACGAAAACTTTGAAAAATA  1680 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1622  TATAAATTCTATTGATCTTGAAACTGAAAATGATGAAACATACGAAAACTTTGAAAAATA  1681 
 
Query  1681  AATTTGATATGTAGTTTCTATATTGCGTAGTTGAGCAGTTTATGA  1725 
             ||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1682  AATTTGATATGTAGTTTCTATATTGCGTAGTTGAGCAGTTTATGA  1726 
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Appendix 3: Catalase gene of strain S10 in comparison with the gene of 
the catalase of S.aureus subsp. aureus NCTC 8325 
gb|CP000253.1|  Staphylococcus aureus subsp. aureus NCTC 8325, complete genome 
Length=2821361 
Features in this part of subject sequence: catalase 
Score = 3092 bits (1674), Expect = 0.0 
Identities = 1708/1725 (99%), Gaps = 0/1725 (0%) 
 
Query  1        GCTTTTTAAGTGTACTATTCAATAACTATTTAGTACTGTAAAGCGaaaaaaaTAAAATTT  60 
                ||||||||||||||||||||||||||||||||||||||||||||||||||| |||||||| 
Sbjct  1269863  GCTTTTTAAGTGTACTATTCAATAACTATTTAGTACTGTAAAGCGAAAAAATTAAAATTT  1269922 
 
Query  61       TCTGATTTTTTAATCATCTTGAGCATGTttaattgtaattctgatggggttaaattataa  120 
                |||||||||||||||||||||||||||||||||||||||| ||||||||||||||||||| 
Sbjct  1269923  TCTGATTTTTTAATCATCTTGAGCATGTTTAATTGTAATTTTGATGGGGTTAAATTATAA  1269982 
 
Query  121      tatgtattaaattataattattataaattGTGGAGGGATGACTATGTCACAACAAGACAA  180 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1269983  TATGTATTAAATTATAATTATTATAAATTGTGGAGGGATGACTATGTCACAACAAGACAA  1270042 
 
Query  181      AAAGTTAACTGGTGTTTTTGGGCATCCAGTATCAGATCGAGAAAATAGTATGACAGCAGG  240 
                |||||||||||||||||||||||||||||||||||| ||||||||||||||||||||||| 
Sbjct  1270043  AAAGTTAACTGGTGTTTTTGGGCATCCAGTATCAGACCGAGAAAATAGTATGACAGCAGG  1270102 
 
Query  241      GCCTAGGGGACCTCTTTTAATGCAAGATATTTACTTTTTAGAGCAAATGTCTCAATTTGA  300 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1270103  GCCTAGGGGACCTCTTTTAATGCAAGATATTTACTTTTTAGAGCAAATGTCTCAATTTGA  1270162 
 
Query  301      TAGAGAAGTAATACCAGAACGTCGAATGCATGCCAAAGGTTCTGGTGCATTTGGGACATT  360 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1270163  TAGAGAAGTAATACCAGAACGTCGAATGCATGCCAAAGGTTCTGGTGCATTTGGGACATT  1270222 
 
Query  361      TACTGTAACTAAAGATATAACAAAATATACGAATGCTAAAATATTCTCTGAAATAGGTAA  420 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1270223  TACTGTAACTAAAGATATAACAAAATATACGAATGCTAAAATATTCTCTGAAATAGGTAA  1270282 
 
Query  421      GCAAACCGAAATGTTTGCCCGTTTCTCTACTGTAGCAGGAGAACGTGGTGCTGCTGATGC  480 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1270283  GCAAACCGAAATGTTTGCCCGTTTCTCTACTGTAGCAGGAGAACGTGGTGCTGCTGATGC  1270342 
 
Query  481      GGAGAGTGACATTCGAGGATTTGCGTTAAAGTTCTACACTGAAGAAGGAAACTGGGATTT  540 
                |||| ||||||||||||||||||||||||||||||||||||||||||| ||||||||||| 
Sbjct  1270343  GGAGCGTGACATTCGAGGATTTGCGTTAAAGTTCTACACTGAAGAAGGGAACTGGGATTT  1270402 
 
Query  541      AGTAGGGAATAACACACCAGTATTCTTCTTTAGAGATCCAAAGCTATTTGTTAGTTTAAA  600 
                ||||||||||||||||||||||||||||||||||||||||||| |||||||||||||||| 
Sbjct  1270403  AGTAGGGAATAACACACCAGTATTCTTCTTTAGAGATCCAAAGTTATTTGTTAGTTTAAA  1270462 
 
Query  601      TCGCGCGGTGAAACGAGATCCTAGAACAAATATGAGAGATGCACAAAATAACTGGGATTT  660 
                ||| |||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1270463  TCGTGCGGTGAAACGAGATCCTAGAACAAATATGAGAGATGCACAAAATAACTGGGATTT  1270522S 
 
Query  661      CTGGACGGGGCTTCCAGAAGCATTGCACCAAGTAACGATCTTAATGTCAGATAGAGGGAT  720 
                ||||||||| |||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1270523  CTGGACGGGTCTTCCAGAAGCATTGCACCAAGTAACGATCTTAATGTCAGATAGAGGGAT  1270582 
 
Query  721      TCCTAAAGATTTACGTCACATGCATGGGTTCGGTTCACACACATACTCTATGTATAATGA  780 
                |||||||||||||||||| ||||||||||||||||| ||||||||||||||||||||||| 
Sbjct  1270583  TCCTAAAGATTTACGTCATATGCATGGGTTCGGTTCTCACACATACTCTATGTATAATGA  1270642 
 
Query  781      TTCTGGTGAACGTGTTTGGGTTAAACTCCATTTTAGAACGCAACAAGGTATTGAAAACTT  840 
                ||||||||||||||||||||||||| |||||||||||||||||||||||||||||||||| 
Sbjct  1270643  TTCTGGTGAACGTGTTTGGGTTAAATTCCATTTTAGAACGCAACAAGGTATTGAAAACTT  1270702 
 
Query  841      AACTGATGAAGAAGCTGCTGAAATTATAGCAACAGGTCGTGATTCATCTCAACGCGATTT  900 
                |||||||||||||||||||||||||||||| |||| |||||||||||||||||||||||| 
Sbjct  1270703  AACTGATGAAGAAGCTGCTGAAATTATAGCTACAGATCGTGATTCATCTCAACGCGATTT  1270762 
 
Query  901      ATTCGAAGCCATTGAAAAAGGTGATTATCCAAAATGGACAATGTATATTCAAGTAATGAC  960 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1270763  ATTCGAAGCCATTGAAAAAGGTGATTATCCAAAATGGACAATGTATATTCAAGTAATGAC  1270822 
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Query  961      TGAGGAACAAGCTAAAAACCATAAAGATAATCCATTTGATTTAACAAAAGTATGGTATCA  1020 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1270823  TGAGGAACAAGCTAAAAACCATAAAGATAATCCATTTGATTTAACAAAAGTATGGTATCA  1270882 
 
Query  1021     CGATGAGTATCCTCTAATTGAAGTTGGAGAGTTTGAATTAAATAGAAATCCAGATAATTA  1080 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1270883  CGATGAGTATCCTCTAATTGAAGTTGGAGAGTTTGAATTAAATAGAAATCCAGATAATTA  1270942 
 
Query  1081     CTTTATGGATGTTGAACAAGTTGCGTTTGCACCAACTAATATTATTCCAGGATTAGATTT  1140 
                |||||||||||||||||||| ||||||||||||||||||||||||||||||||||||||| 
Sbjct  1270943  CTTTATGGATGTTGAACAAGCTGCGTTTGCACCAACTAATATTATTCCAGGATTAGATTT  1271002 
 
Query  1141     TTCTCCAGACAAAATGCTGCAAGGGCGTTTATTCTCATATGGCGATGCGCAAAGATATTG  1200 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||| | 
Sbjct  1271003  TTCTCCAGACAAAATGCTGCAAGGGCGTTTATTCTCATATGGCGATGCGCAAAGATATCG  1271062 
 
Query  1201     ATTAGGAGTTAATCATTGGCAGATTCCTGTAAACCAACCTAAAGGTGTGGGTATTGAAAA  1260 
                |||||||||||||||||||||||||||||||||||||||||||||||| ||||||||||| 
Sbjct  1271063  ATTAGGAGTTAATCATTGGCAGATTCCTGTAAACCAACCTAAAGGTGTTGGTATTGAAAA  1271122 
 
Query  1261     TATTTGTCCTTTTAGTAGAGATGGTCAAATGCGCGTAGTTGACAATAACCAAGGTGGAGG  1320 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1271123  TATTTGTCCTTTTAGTAGAGATGGTCAAATGCGCGTAGTTGACAATAACCAAGGTGGAGG  1271182 
 
Query  1321     AACACATTATTATCCAAATAACCATGGTAAATTTGATTCTCAACCTGAATATAAAAAGCC  1380 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1271183  AACACATTATTATCCAAATAACCATGGTAAATTTGATTCTCAACCTGAATATAAAAAGCC  1271242 
 
Query  1381     ACCATTCCCAACTGATGGATACGGCTATGAATATAATCAACGTCAAGATGATGATAATTA  1440 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1271243  ACCATTCCCAACTGATGGATACGGCTATGAATATAATCAACGTCAAGATGATGATAATTA  1271302 
 
Query  1441     TTTTGAACAACCAGGTAAATTGTTTAGATTACAATCAGAGGGCGCTAAAGAAAGAATTTT  1500 
                ||||||||||||||||||||||||||||||||||||||||| |||||||||||||||||| 
Sbjct  1271303  TTTTGAACAACCAGGTAAATTGTTTAGATTACAATCAGAGGACGCTAAAGAAAGAATTTT  1271362 
 
Query  1501     TACAAATACAGCAAATGCAATGGAAGGCGTAACGGATGATGTTAAACGACGTCATATTCG  1560 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1271363  TACAAATACAGCAAATGCAATGGAAGGCGTAACGGATGATGTTAAACGACGTCATATTCG  1271422 
 
Query  1561     TCATTGTTACAAAGCTGACCCAGAATATGGTAAAGGTGTTGCAAAAGCATTAGGTATTGA  1620 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1271423  TCATTGTTACAAAGCTGACCCAGAATATGGTAAAGGTGTTGCAAAAGCATTAGGTATTGA  1271482 
 
Query  1621     TATAAATTCTATTGATCTTGAAACTGAAAATGATGAAACATACGAAAACTTTGAAAAATA  1680 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1271483  TATAAATTCTATTGATCTTGAAACTGAAAATGATGAAACATACGAAAACTTTGAAAAATA  1271542 
 
Query  1681     AATTTGATATGTAGTTTCTATATTGCGTAGTTGAGCAGTTTATGA  1725 
                ||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1271543  AATTTGATATGTAGTTTCTATATTGCGTAGTTGAGCAGTTTATGA  1271587 
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Appendix 4: Translated sequence of the catalase gene of strain S10 in 
comparison with the amino acid sequence of catalase of other S. aureus 
strains  
> ref|NP_646038.1|  Catalase [Staphylococcus aureus subsp. aureus MW2] 
 ref|YP_043399.1|  catalase [Staphylococcus aureus subsp. aureus MSSA476] 
 ref|YP_493929.1|  catalase [Staphylococcus aureus subsp. aureus USA300] 
 ref|YP_001246765.1|  Catalase [Staphylococcus aureus subsp. aureus JH9] 
 ref|YP_001316559.1|  Catalase [Staphylococcus aureus subsp. aureus JH1] 
 sp|Q6G9M4|CATA_STAAS  Catalase 
 sp|Q8NWV5|CATA_STAAW  Catalase 
 sp|Q5HG86|CATA_STAAC  Catalase 
 sp|Q99UE2|CATA_STAAM  Catalase 
 sp|Q7A5T2|CATA_STAAN  Catalase 
 sp|Q2FH99|CATA_STAA3  Catalase 
 sp|Q2FYU7|CATA_STAA8  Catalase 
 sp|Q2YXT2|CATA_STAAB  Catalase 
 dbj|BAB95086.1|  Catalase [Staphylococcus aureus subsp. aureus MW2] 
 emb|CAG43052.1|  catalase [Staphylococcus aureus subsp. aureus MSSA476] 
 gb|ABD20999.1|  catalase [Staphylococcus aureus subsp. aureus 
USA300_FPR3757] 
 gb|ABQ49189.1|  Catalase [Staphylococcus aureus subsp. aureus JH9] 
 gb|ABR52272.1|  Catalase [Staphylococcus aureus subsp. aureus JH1] 
Length=505 
 Score = 1043 bits (2697), Expect = 0.0 
 Identities = 499/505 (98%), Positives = 499/505 (98%), Gaps = 0/505 (0%) 
 Frame = +2 
 
Query  164   MSQQDKKLTGVFGHPVSDRENSMTAGPRGPLLMQDIYFLEQMSQFDREVIPERRMHAKGS  343 
             MSQQDKKLTGVFGHPVSDRENSMTAGPRGPLLMQDIYFLEQMSQFDREVIPERRMHAKGS 
Sbjct  1     MSQQDKKLTGVFGHPVSDRENSMTAGPRGPLLMQDIYFLEQMSQFDREVIPERRMHAKGS  60 
 
Query  344   GAFGTFTVTKDITKYTNAKIFSEIGKQTEMFARFSTVAGERGAADAESDIRGFALKFYTE  523 
             GAFGTFTVTKDITKYTNAKIFSEIGKQTEMFARFSTVAGERGAADAE DIRGFALKFYTE 
Sbjct  61    GAFGTFTVTKDITKYTNAKIFSEIGKQTEMFARFSTVAGERGAADAERDIRGFALKFYTE  120 
 
Query  524   EGNWDLVGNNTPVFFFRDPKLFVSLNRAVKRDPRTNMRDAQNNWDFWTGLPEALHQVTIL  703 
             EGNWDLVGNNTPVFFFRDPKLFVSLNRAVKRDPRTNMRDAQNNWDFWTGLPEALHQVTIL 
Sbjct  121   EGNWDLVGNNTPVFFFRDPKLFVSLNRAVKRDPRTNMRDAQNNWDFWTGLPEALHQVTIL  180 
 
Query  704   MSDRGIPKDLRHMHGFGSHTYSMYNDSGERVWVKLHFRTQQGIENLTDEEAAEIIATGRD  883 
             MSDRGIPKDLRHMHGFGSHTYSMYNDSGERVWVK HFRTQQGIENLTDEEAAEIIAT RD 
Sbjct  181   MSDRGIPKDLRHMHGFGSHTYSMYNDSGERVWVKFHFRTQQGIENLTDEEAAEIIATDRD  240 
 
Query  884   SSQRDLFEAIEKGDYPKWTMYIQVMTEEQAKNHKDNPFDLTKVWYHDEYPLIEVGEFELN  1063 
             SSQRDLFEAIEKGDYPKWTMYIQVMTEEQAKNHKDNPFDLTKVWYHDEYPLIEVGEFELN 
Sbjct  241   SSQRDLFEAIEKGDYPKWTMYIQVMTEEQAKNHKDNPFDLTKVWYHDEYPLIEVGEFELN  300 
 
Query  1064  RNPDNYFMDVEQVAFAPTNIIPGLDFSPDKMLQGRLFSYGDAQRY*LGVNHWQIPVNQPK  1243 
             RNPDNYFMDVEQ AFAPTNIIPGLDFSPDKMLQGRLFSYGDAQRY LGVNHWQIPVNQPK 
Sbjct  301   RNPDNYFMDVEQAAFAPTNIIPGLDFSPDKMLQGRLFSYGDAQRYRLGVNHWQIPVNQPK  360 
 
Query  1244  GVGIENICPFSRDGQMRVVDNNQGGGTHYYPNNHGKFDSQPEYKKPPFPTDGYGYEYNQR  1423 
             GVGIENICPFSRDGQMRVVDNNQGGGTHYYPNNHGKFDSQPEYKKPPFPTDGYGYEYNQR 
Sbjct  361   GVGIENICPFSRDGQMRVVDNNQGGGTHYYPNNHGKFDSQPEYKKPPFPTDGYGYEYNQR  420 
 
Query  1424  QDDDNYFEQPGKLFRLQSEGAKERIFTNTANAMEGVTDDVKRRHIRHCYKADPEYGKGVA  1603 
             QDDDNYFEQPGKLFRLQSE AKERIFTNTANAMEGVTDDVKRRHIRHCYKADPEYGKGVA 
Sbjct  421   QDDDNYFEQPGKLFRLQSEDAKERIFTNTANAMEGVTDDVKRRHIRHCYKADPEYGKGVA  480 
 
Query  1604  KALGIDINSIDLETENDETYENFEK  1678 
             KALGIDINSIDLETENDETYENFEK 
Sbjct  481   KALGIDINSIDLETENDETYENFEK  505 
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Appendix 5: Translated sequence of the catalase gene of S10 in 
comparison with the amino acid sequence of the catalase-like protein of 
S. aureus subps. anaerobius strain MVF 213  
 
> sp|Q9L4S2|CATB_STAAA  Catalase-like protein 
 emb|CAB76840.1|  Catalase [Staphylococcus aureus] 
Length=455 
 Score = 927 bits (2396), Expect (2) = 0.0 
 Identities = 443/445 (99%), Positives = 443/445 (99%), Gaps = 0/445 (0%) 
 Frame = +2 
 
Query 164 MSQQDKKLTGVFGHPVSDRENSMTAGPRGPLLMQDIYFLEQMSQFDREVIPERRMHAKGS 343 
           MSQQDKKLTGVFGHPVSDRENSMTAGPRGPLLMQDIYFLEQMSQFDREVIPERRMHAKGS 
Sbjct  1   MSQQDKKLTGVFGHPVSDRENSMTAGPRGPLLMQDIYFLEQMSQFDREVIPERRMHAKGS  60 
 
Query  344 GAFGTFTVTKDITKYTNAKIFSEIGKQTEMFARFSTVAGERGAADAESDIRGFALKFYTE  523 
           GAFGTFTVTKDITKYTNAKIFSEIGKQTEMFARFSTVAGERGAADAESDIRGFALKFYTE 
Sbjct  61  GAFGTFTVTKDITKYTNAKIFSEIGKQTEMFARFSTVAGERGAADAESDIRGFALKFYTE  120 
 
Query  524 EGNWDLVGNNTPVFFFRDPKLFVSLNRAVKRDPRTNMRDAQNNWDFWTGLPEALHQVTIL  703 
           EGNWDLVGNNTPVFFFRDPKLFVSLNRAVKRDPRTNMRDAQNNWDFWTGLPEALHQVTIL 
Sbjct  121 EGNWDLVGNNTPVFFFRDPKLFVSLNRAVKRDPRTNMRDAQNNWDFWTGLPEALHQVTIL  180 
 
Query  704 MSDRGIPKDLRHMHGFGSHTYSMYNDSGERVWVKLHFRTQQGIENLTDEEAAEIIATGRD  883 
           MSDRGIPKDLRHMHGFGSHTYSMYNDSGERVWVKLHFRTQQGIENLTDEEAAEIIATGRD 
Sbjct  181 MSDRGIPKDLRHMHGFGSHTYSMYNDSGERVWVKLHFRTQQGIENLTDEEAAEIIATGRD  240 
 
Query 884  SSQRDLFEAIEKGDYPKWTMYIQVMTEEQAKNHKDNPFDLTKVWYHDEYPLIEVGEFELN  1063 
           SSQRDLFEAIEKGDYPKWTMYIQVMTEEQAKNHKDNPFDLTKVWYHDEYPLIEVGEFELN 
Sbjct 241  SSQRDLFEAIEKGDYPKWTMYIQVMTEEQAKNHKDNPFDLTKVWYHDEYPLIEVGEFELN  300 
  
Query1064  RNPDNYFMDVEQVAFAPTNIIPGLDFSPDKMLQGRLFSYGDAQRY*LGVNHWQIPVNQPK  1243 
           RNPDNYFMDVEQVAFA TNIIPGLDFSPDKMLQGRLFSYGDAQRY LGVNHWQIPVNQPK 
Sbjct 301  RNPDNYFMDVEQVAFASTNIIPGLDFSPDKMLQGRLFSYGDAQRYRLGVNHWQIPVNQPK  360 
 
Query1244  GVGIENICPFSRDGQMRVVDNNQGGGTHYYPNNHGKFDSQPEYKKPPFPTDGYGYEYNQR  1423 
           GVGIENICPFSRDGQMRVVDNNQGGGTHYYPNNHGKFDSQPEYKKPPFPTDGYGYEYNQR 
Sbjct 361  GVGIENICPFSRDGQMRVVDNNQGGGTHYYPNNHGKFDSQPEYKKPPFPTDGYGYEYNQR  420 
 
Query1424  QDDDNYFEQPGKLFRLQSEGAKERI  1498 
           QDDDNYFEQPGKLFRLQSEGAKERI 
Sbjct 421  QDDDNYFEQPGKLFRLQSEGAKERI  445 
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Appendix 6: Partial sequence of the catalase gene of S. aureus subsp.  
anaerobius strain K41 isolated from lymph node abscess of sheep at meat 
inspection in Alkadaro slaughter house, Khartoum North, Sudan 
TCtACTGTAGCaGGaGAACGTGgTGCTGCTGATGCGGAGAGTGACATtCGAGGATTTGCGTTAAAGTTCTACaCTGAAGAaGGAAA
CTGGGATTTAGTAGGGAATAACACACCAGTATTCTTCTTTAGAGATCCAAAGCTATTTGTTAGTTTAAATCGCGCGGTGAAACGAG
ATCCTAGAACAAATATGAGAGATGCACAAAATAACTGGGATTTCTGGACGGGGCTTCCAGAAGCATTGCACCAAGTAACGATCTTA
ATGTCAGATAGAGGGATTCCTAAAGATTTACGTCACATGCATGGGTTCGGTTCACACACATACTCTATGTATAATGATTCTGGTGA
ACGTGTTTGGGTTAAACTCCATTTTAGAACGCAACAAGGTATTGAAAACTTAACTGATGAAGAAGCTGCTGAAATTATAGCAACAG
GTCGTGATTCATCTCAACGCGATTTATTCGAAGCCATTGAAAAAGGTGATTATCCAAAATGGACAATGTATATTCAAGTAATGACT
GAGGAACAAGCTAAAAACCATAAAGATAATCCATTTGATTTAACAAAAGTATGGTATCACGATGAGTATCCTCTAATTGAAGTTGG
AGAGTTTGAATTAAATAGAAATCCAGATAATTACTTTATGGATGTTGAACAAGTTGCGTTTGCACCAACTAATATTATTCCAGGAT
TAGATTTTTCTCCAGACAAAATGCTGCAAGGGCGTTTATTCTCATATGGCGATGCGCAAAGATATTGATTAGGAGTTAATCATTGG
CAGATTCCTGTAAACCAACCTAAAGGTGTGGGTATTGAAAATATTTGTCCTTTTAGTAGAGATGGTCAAATGCGCGTAGTTGACAA
TAACCAAGGTGGAGGAACACATTATTATCCAAATAACCATGGTAAATTTGATTCTCAACCTGAATATAAAAAGCCACCATTCCCAA
CTGATGGATACGGCTATGAATATAATCAACGTCAAGATGATGATAATTATTTTGAACAACCAGGTAAATTGTTTAGATTACAATCA
GAGGGCGCTAAAGAAAGAATTTTTACAAATACAGCAAATGCAATGGAAGGCGTAACGGATGATGTTAAACGACG 
 
Appendix 7: Partial sequence of the catalase gene of S. aureus subsp.  
anaerobius strain S19 isolated from outbreak of Morel’s disease in 
Alsamra village, Khartoum North, Sudan 
AACTGgGATTTAGTAGGGAATAACACACCAGTATTCTTCTTTAGAGATCCAAAGCTATTTGTTAGTTTAAATCGCGCGGTGAAACG
AGATCCTAGAACAAATATGAGAGATGCACAAAATAACTGGGATTTCTGGACGGGGCTTCCAGAAGCATTGCACCAAGTAACGATCT
TAATGTCAGATAGAGGGATTCCTAAAGATTTACGTCACATGCATGGGTTCGGTTCACACACATACTCTATGTATAATGATTCTGGT
GAACGTGTTTGGGTTAAACTCCATTTTAGAACGCAACAAGGTATTGAAAACTTAACTGATGAAGAAGCTGCTGAAATTATAGCAAC
AGGTCGTGATTCATCTCAACGCGATTTATTCGAAGCCATTGAAAAAGGTGATTATCCAAAATGGACAATGTATATTCAAGTAATGA
CTGAGGAACAAGCTAAAAACCATAAAGATAATCCATTTGATTTAACAAAAGTATGGTATCACGATGAGTATCCTCTAATTGAAGTT
GGAGAGTTTGAATTAAATAGAAATCCAGATAATTACTTTATGGATGTTGAACAAGTTGCGTTTGCACCAACTAATATTATTCCAGG
ATTAGATTTTTCTCCAGACAAAATGCTGCAAGGGCGTTTATTCTCATATGGCGATGCGCAAAGATATTGATTAGGAGTTAATCATT
GGCAGATTCCTGTAAACCAACCTAAAGGTGTGGGTATTGAAAATATTTGTCCTTTTAGTAGAGATGGTCAAATGCGCGTAGTTGAC
AATAACCAAGGTGGAGGAACACATTATTATCCAAATAACCATGGTAAATTTGATTCTCAACCTGAATATAAAAAGCCACCATTCCC
AACTGATGGATACGGCTATGAATATAATCAACGTCAAGATGATGATAATTATTTTGAACAACCAGGTAAATTGTTTAGATTACAAT
CAGAGGGCGCTAAAGAAAGAATTTTTACAAATACAGCAAATGCAATGGAAGGCGTAACGGATGATGTTAAACGACG 
 
Appendix 8: Partial sequence of the catalase gene of S. aureus subsp.  
anaerobius strain G2 isolated from lymph node abscess of sheep at meat 
inspection in Ghanawa slaughter house, Omdurman, Sudan 
CACACCAGTATTCTTCTTTAGAGATCCAAAGCTATTTGTTAGTTTAAATCGCGCGGTGAAACGAGATCCTAGAACAAATATGAGAG
ATGCACAAAATAACTGGGATTTCTGGACGGGGCTTCCAGAAGCATTGCACCAAGTAACGATCTTAATGTCAGATAGAGGGATTCCT
AAAGATTTACGTCACATGCATGGGTTCGGTTCACACACATACTCTATGTATAATGATTCTGGTGAACGTGTTTGGGTTAAACTCCA
TTTTAGAACGCAACAAGGTATTGAAAACTTAACTGATGAAGAAGCTGCTGAAATTATAGCAACAGGTCGTGATTCATCTCAACGCG
ATTTATTCGAAGCCATTGAAAAAGGTGATTATCCAAAATGGACAATGTATATTCAAGTAATGACTGAGGAACAAGCTAAAAACCAT
AAAGATAATCCATTTGATTTAACAAAAGTATGGTATCACGATGAGTATCCTCTAATTGAAGTTGGAGAGTTTGAATTAAATAGAAA
TCCAGATAATTACTTTATGGATGTTGAACAAGTTGCGTTTGCACCAACTAATATTATTCCAGGATTAGATTTTTCTCCAGACAAAA
TGCTGCAAGGGCGTTTATTCTCATATGGCGATGCGCAAAGATATTGATTAGGAGTTAATCATTGGCAGATTCCTGTAAACCAACCT
AAAGGTGTGGGTATTGAAAATATTTGTCCTTTTAGTAGAGATGGTCAAATGCGCGTAGTTGACAATAACCAAGGTGGAGGAACACA
TTATTATCCAAATAACCATGGTAAATTTGATTCTCAACCTGAATATAAAAAGCCACCATTCCCAACTGATGGATACGGCTATGAAT
ATAATCAACGTCAAGATGATGATAATTATTTTGAACAACCAGGTAAATTGTTTAGATTACAATCAGAGGGCGCTAAAGAAAGAATT
TTTACAAATACAGCAAATGCAATGGAAGGCGTAACGGATGATGTTAAACGACG 
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Appendix 9: Partial sequence of the catalase gene of S. aureus subsp.  
anaerobius strain ATCC35844, DSM no. 20714  
CTGGGAtTTAGTAGGGAATAACACACCAGTATTCTTCTTTAGAGATCCAAAGCTATTTGTTAGTTTAAATCGCGCGGTGAAACGAG
ATCCTAGAACAAATATGAGAGATGCACAAAATAACTGGGATTTCTGGACGGGGCTTCCAGAAGCATTGCACCAAGTAACGATCTTA
ATGTCAGATAGAGGGATTCCTAAAGATTTACGTCACATGCATGGGTTCGGTTCACACACATACTCTATGTATAATGATTCTGGTGA
ACGTGTTTGGGTTAAACTCCATTTTAGAACGCAACAAGGTATTGAAAACTTAACTGATGAAGAAGCTGCTGAAATTATAGCAACAG
GTCGTGATTCATCTCAACGCGATTTATTCGAAGCCATTGAAAAAGGTGATTATCCAAAATGGACAATGTATATTCAAGTAATGACT
GAGGAACAAGCTAAAAACCATAAAGATAATCCATTTGATTTAACAAAAGTATGGTATCACGATGAGTATCCTCTAATTGAAGTTGG
AGAGTTTGAATTAAATAGAAATCCAGATAATTACTTTATGGATGTTGAACAAGTTGCGTTTGCATCAACTAATATTATTCCAGGAT
TAGATTTTTCTCCAGACAAAATGCTGCAAGGGCGTTTATTCTCATATGGCGATGCGCAAAGATATCGATTAGGAGTTAATCATTGG
CAGATTCCTGTAAACCAACCTAAAGGTGTGGGTATTGAAAATATTTGTCCTTTTAGTAGAGATGGTCAAATGCGCGTAGTTGACAA
TAACCAAGGTGGAGGAACACATTATTATCCAAATAACCATGGTAAATTTGATTCTCAACCTGAATATAAAAAGCCACCATTCCCAA
CTGATGGATACGGCTATGAATATAATCAACGTCAAGATGATGATAATTATTTTGAACAACCAGGTAAATTGTTTAGATTACAATCA
GAGGGCGCTAAAGAAAGAATTTTACAAATACAGCAAATGCAATGGAAGGCGTAACGGATGATGTTAAACGAC 
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Abstract 
 
We report here for an outbreak of abscess disease in a flock of sheep in Al Samra village, 
Khartoum North, Sudan. The flock consisted of 100 animals of different ages ranging from 4 
- 12 months. The animals were free grazing during the daytime and they were kept in a pen at 
the evenings, where they receive some type of feed supplemented with concentrates. Thirty 
animals were showing one or two abscess of superficial (prescapular or parotid) lymph nodes. 
Abscesses were round with diameter of 4 - 10 cm, soft in consistency when palpated. All 
abscesses were incised following aseptical proceures (shaving, rubbing with tincture of iodine 
and 70% alcohol) and the contents were expelled from which samples were taken in sterile 
containers. The contents of almost all abscesses were odourless, viscid, yellowish white to 
creamy in colour and were enclosed in a thick connective tissue capsule. Bacteriological 
examination of the contents of abscesses of 28 (93.33 %) animals revealed pure cultures of 
Gram-positive cocci arranged in pairs, tetrads and clusters. Biochemical tests for these 
bacteria were typical to those of Staphylococcus aureus subspecies anaerobius, the 
aetiological agent of sheep abscess disease, which was firstly described by Morel in 1911 in 
France. Abscesses of the remaining two animals yielded growth of Corynebacterium spp., the 
causative agent of caseous lymphadenitis of sheep. Results of this report confirm findings of 
previous investigations on abscess syndromes of sheep in the Sudan, in which Staph. aureus 
subsp. anaerobius was found to be the first organism to be incriminated in superficial lymph 
node abscess in sheep, especially of small ages and in sheep in steaming up operations. 
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ABSTRACT 
Staphylococcus aureus subspecies anaerobius strain S10 was isolated from outbreak 
of sheep abscess disease. Sequence of the catalase gene of this strain showed 99% 
identity to the catalase gene (katB) sequence of the reference strain (S. aureus subsp. 
anaerobius strain MVF213) with mismatching of three base pairs. An important 
substitution located 1036 nucleotides upstream the initiation codon from “C” in katB 
to “T” in the catalase gene of strain S10 originated a stop codon. The deduced protein 
(345 amino acids) is 105 amino acids shorter than that of katB. Partial sequence (600 
– 990 bp) of the catalase gene of other eight local isolates in addition to another 
reference strain (DSM no. 20714) revealed the same mutations in all local (African) 
strains, whereas sequence of the reference (European) strain was typical to that of 
katB. Sequence of the catalase gene of S. aureus subsp. anaerobius stain S10 was 
deposited in the GenBank under accession no. EU281993. 
Keywords: catalase gene, sheep abscess disease, Staphylococcus aureus subspecies 
anaerobius. 
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INTRODUCTION  
Anaerobic Staphylococcus aureus bacteria are the causal agent of sheep abscess or 
Morel’s disease (Bajmócy et al., 1984, Hamad et al., 1992). Although these bacteria 
are considered apathogenic to man, a report on a case of septicaemia due to one strain 
of these bacteria in man has recently been published (Peake et al., 2006). These 
bacteria were separated from other S. aureus bacteria in a subspecies (S. aureus 
subspecies anaerobius) because of their negative or weak growth in normal air, lack 
of the catalase enzyme activity in addition to some other biochemical properties (de la 
Fuente et al., 1985). Although some strains of S. aureus subsp. aureus were reported 
to lack this catalase enzyme activity (Tu et al., 1976, Friedberg et al., 2003, Yelmaz et 
al., 2005), they still grow well under aerobic conditions (Grüner et al., 2007). 
Comparative studies between the catalase genes of S. aureus subsp. aureus and S. 
aureus subsp. anaerobius (katA and katB, respectively) showed that katA had 
undergone mutations led to deletion of one base pair in addition to 8 silent and 6 mis-
sense mutations (Sanz et al., 2000). The deletion resulted in shift of the reading frame 
and premature termination of translation with subsequent generation of katB, which 
codes for a protein 55 amino acid residues shorter than katA. Lack of the catalase 
activity of S. aureus subsp. anaerobius is attributed to some of these mutations (Sanz 
et al., 2000). Loss of the catalase enzyme activity in some strains of S. aureus subsp. 
aureus was also attributed to mutations of the catalase gene (katA). While in a 
methicillin resistant S. aureus subsp. aureus strain deletion of five successive base 
pairs leading to shift in the reading frame and premature termination of translation 
(Grüner et al., 2007), substitution of a key amino acid in the protein (histidine 58 by 
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atyrosine) led to inactivity of this gene in methicillin sensitive S. aureus subsp. aureus 
strain (Piau et al., 2008). 
We report here for some strains of S. aureus subsp. anaerobius that harbour a catalase 
gene that underwent mutations other than those previously reported for the European 
strains. 
MATERIALS AND METHODS 
Bacterial strains 
S. aureus subsp. anaerobius strain S10 (SaanS10) was isolated from superficial lymph 
node abscess of one lamb in a flock of sheep during outbreak of Morel’s disease in 
Alsamra village, East Nile Province of the Sudan, as has previously been reported 
(Musa et al., 2007). Other isolates and strains used in this study were as follows: two 
isolates from animals in the same disease outbreak, 6 isolates from superficial lymph 
node abscesses of sheep at meat inspection in abattoirs located in two different areas 
of Khartoum State, and S. aureus subsp. anaerobius DSM no. 20714 as reference 
strain. Identification of the isolates was based on failure of aerobic growth within 48 
h, lack of catalase activity, positive coagulase activity, in addition to the fermentation 
ability of some sugars. All tests were done according to standards methods (Barrow 
and Feltham, 1993). 
DNA extraction 
Genomic DNA was extracted using Axy Prep Bacterial Genomic DNA Miniprep Kit 
of Axygen (Bioron, Ludwigshafen, Germany) with some modifications of the 
manufacturer’s protocol. In brief, 3-5 colonies from 48 h blood agar culture were 
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suspended in 150 µl of the recommended buffer. Lysis of the cells was achieved by 
treatment with 10 µl of 1% lysostaphin (Sigma, Taufkirchen, Germany) for 1 h at 37 
°C followed by addition of 2 µl of 10% Proteinase K (Bioron) at 56 °C for 2 h. The 
follow-up steps were carried out according to the manufacturer’s protocol. 
PCR 
 To confirm the biochemical identification of the isolates, a conserved region of the 
thermonuclease gene (nuc gene) of S. aureus was amplified by PCR using primers 
and conditions previously described (Brakstad et al., 1992). 
Sequencing of the catalase gene 
 In order to amplify and sequence the whole catalase gene of SaanS10 and to partially 
sequence the catalase gene of the other isolates, primers and conditions previously 
described for the amplification of katA and katB (Sanz et al., 2000) in addition to 
other primers designed for this purpose were used (Table 1). Sequencing was done by 
Seqlab (Göttingen, Germany). For confirmation of the sequence results, both strands 
were sequenced, or overlapping parts of the gene were sequenced. Sequences were 
edited using a software program (BioEdit, Version 7.0.5.3). Alignment and 
comparisons were done using the Basic Local Alignment Search Tool (BLAST) of 
NCBI. The resulting sequence was deposited in the GenBank under accession no. 
EU281993. 
RESULTS AND DISCUSSION 
Identification of the isolates by biochemical tests could be confirmed by PCR 
amplification of the nuclease and catalase genes to the species level only (i.e. S. 
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aureus) but not to the subspecies level. Further genetic characterization could be made 
by sequencing the catalase gene. Sequence of the putative catalase gene of S. aureus 
subsp. anaerobius strain S10 (SaanS10) showed 99% identity to katB gene of S. 
aureus subsp. anaerobius MVF213 (GenBank accession no. AJ000471), katA gene of 
S. aureus subsp. aureus strains NCTC 8325 and Newman (GenBank accession 
nos.CP000253 and AP009351.1, respectively) and some other strains. The whole 
amplified part of the putative catalase gene of SaanS10 (katS10) was 1725 nucleotides 
in length. Comparison of this sequence with katB sequence revealed mismatches of 
only three bases. But, in comparison with katA 15 bases substitutions occurred within 
the coding region of katA, six of which were mis-sense mutations while the others 
were silent mutations. An important substitution occurred at position no. 1099 (1036 
bases upstream the initiation codon) of katS10 gene. In katS10 the base is “T”, while 
in katA and katB it is “C”. This substitution resulted in the code "TGA" instead of 
"CGA". This code for termination of translation rendered the predicted protein to be 
only 345 amino acids in length. In S. aureus subsp. aureus (NCTC 8325 and Newman 
strains) the protein of katA is 505 a.a. long. In S. aureus subsp. anaerobius strain 
MVF213, which is catalase negative, the catalase-like protein of katB is 445 a.a. long. 
Loss of the catalase activity of S. aureus subsp. anaerobius is attributed to deletion of 
one base 1338 nucleotides upstream the initiation codon, which resulted in shift in the 
reading frame and premature termination of translation 30 bases later (Sanz et al., 
2000). In katS10 this deletion is absent, a feature of similarity to katA. The third 
mismatching of katS10 and katB is that the substitution which occurred at base 949 
upstream the initiation codon leading to serine in katB instead of proline in katA (Sanz 
et al., 2000) did happen in katS10. Interestingly, all mutations, except the above 
mentioned ones, occurred in katA gene leading to the generation of katB did also 
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occur in katS10. This suggests that katA underwent mutations in at least two steps 
leading to the generation of katB and katS10. 
To see if these mutations of katS10 are unique features of SaanS10 or common to 
other S. aureus subsp. anaerobius local strains, partial sequence (600- 990 bp) of the 
catalase genes of other eight isolates in addition to a reference strain (S. aureus subsp. 
anaerobius DSM no 20714) was performed. The segment of the gene chosen for this 
partial sequence targeted a region that contained most of the mutations seen in katS10 
including position 1099 of the gene. The sequence of the catalase gene of all local 
isolates was identical to that of katS10, while that of the reference strain was identical 
to katB sequence. 
S. aureus subsp. anaerobius strain MVF213 was originally isolated from lamb 
affected with abscess disease in Spain. The mutations found in this strain leading to 
the generation of katB were also found in three other strains isolated from lambs 
affected with the same disease in Spain at different years (Sanz et al., 2000). The 
Spanish strains thus seem to have originated from one clone (European clone), and the 
local strains harbouring katS10 seem to originate from another genetically distinct 
clone (African clone). This assumption can be augmented by the results of Elhaj and 
El Sanousi (2005) who found that local isolates of S. aureus subsp. anaerobius were 
identical, but distinct from the reference strain, in the DNA restriction pattern in 
PFGE.  
In conclusion, results of this study show clear differentiation between local and 
reference strains of S. aureus subsp.  anaerobius on the base of the catalase gene 
sequence. However, the potential use of the catalase gene as gene marker for typing 
strains of S. aureus subsp. anaerobius requires further investigations including more 
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international strains of both S. aureus subsp.  anaerobius and catalase negative S. 
aureus subsp. aureus.  
To the best of our knowledge, this is the second report on the catalase-like protein 
gene of S. aureus subsp. anaerobius and the fourth on a non-functional catalase gene 
of S. aureus in general. 
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Table 1: Oligonucleotides used in this study 
Primer Sequence Gene Source 
Nuc F 5´ GCGATTGATGGTGATACGGTT 3´ Thermo- 
nuclease 
Brakstad et al. 
(1992) 
Nuc R 5´ AGCCAAGCCTTGACGAACTAAAGC 3´ Thermo- 
nuclease 
Brakstad et al. 
(1992) 
3 F 5´ GCTTTTTAAGTGTACTATTC 3´ Catalase This study 
a
 
164 F 5´ TATAAATTGTGGAGGGATGAC 3´ Catalase Sanz et al. (2000) 
8 F 5´ CTCCATTTTAGAACGCAACAA 3´ Catalase Sanz et al. (2000) 
1396 F 5´ GATGGATACGGCTATGAATA 3´ Catalase This study 
a
 
872 R 5´ GCTATAATTTCAGCAGCTTC  3´ Catalase This study 
a
 
1583 R 5´ TGGGTCAGCTTTGTAACA 3´ Catalase Sanz et al. (2000) 
1726 R 5´ TCATAAACTGCTCAACTACGC 3´ Catalase Sanz et al. (2000) 
a 
The primers were designed based on the sequences of the catalase genes of 
Staphylococcus aureus strain MVF213 (GenBank accession no. AJ000471) and S. 
aureus strain ATCC12600 (GenBank accession no. AJ000472) 
 
 
